CA2633593A1 - Methode de diagnostic, de pronostic et de traitement du gliome - Google Patents

Methode de diagnostic, de pronostic et de traitement du gliome Download PDF

Info

Publication number: CA2633593A1
Authority: CA; Canada
Prior art keywords: antibody; tumor; antagonist; mes; prolif
Prior art date: 2005-12-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002633593A

Other languages

English (en)

Inventor

William F. Forrest

Samir Kharbanda

Heidi Phillips

Thomas D. Wu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genentech Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-16

Filing date

2006-12-11

Publication date

2007-10-04

2006-12-11 Application filed by Individual filed Critical Individual

2007-10-04 Publication of CA2633593A1 publication Critical patent/CA2633593A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 159
206010018338 Glioma Diseases 0.000 title claims abstract description 120
208000032612 Glial tumor Diseases 0.000 title claims abstract description 94
206010028980 Neoplasm Diseases 0.000 claims abstract description 306
239000005557 antagonist Substances 0.000 claims abstract description 183
230000014509 gene expression Effects 0.000 claims abstract description 104
239000003795 chemical substances by application Substances 0.000 claims abstract description 70
229940127276 delta-like ligand 3 Drugs 0.000 claims abstract description 53
108010011536 PTEN Phosphohydrolase Proteins 0.000 claims abstract description 50
230000001537 neural effect Effects 0.000 claims abstract description 49
230000004083 survival effect Effects 0.000 claims abstract description 48
230000004069 differentiation Effects 0.000 claims abstract description 37
239000004037 angiogenesis inhibitor Substances 0.000 claims abstract description 22
239000003080 antimitotic agent Substances 0.000 claims abstract description 21
230000001225 therapeutic effect Effects 0.000 claims abstract description 21
238000012544 monitoring process Methods 0.000 claims abstract description 4
102000014160 PTEN Phosphohydrolase Human genes 0.000 claims abstract 13
101000928513 Homo sapiens Delta-like protein 3 Proteins 0.000 claims abstract 11
102100036466 Delta-like protein 3 Human genes 0.000 claims abstract 10
108090000765 processed proteins & peptides Proteins 0.000 claims description 152
102000004196 processed proteins & peptides Human genes 0.000 claims description 146
230000027455 binding Effects 0.000 claims description 139
229920001184 polypeptide Polymers 0.000 claims description 138
239000000427 antigen Substances 0.000 claims description 73
108091007433 antigens Proteins 0.000 claims description 70
102000036639 antigens Human genes 0.000 claims description 70
239000000523 sample Substances 0.000 claims description 56
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 55
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 55
150000007523 nucleic acids Chemical group 0.000 claims description 53
108091008611 Protein Kinase B Proteins 0.000 claims description 52
239000012634 fragment Substances 0.000 claims description 46
102000015636 Oligopeptides Human genes 0.000 claims description 42
108010038807 Oligopeptides Proteins 0.000 claims description 42
230000012010 growth Effects 0.000 claims description 39
108091028043 Nucleic acid sequence Proteins 0.000 claims description 35
239000000556 agonist Substances 0.000 claims description 31
-1 ironotecan Chemical compound 0.000 claims description 27
230000002401 inhibitory effect Effects 0.000 claims description 26
229940127089 cytotoxic agent Drugs 0.000 claims description 25
239000003446 ligand Substances 0.000 claims description 25
150000003384 small molecules Chemical class 0.000 claims description 25
210000004881 tumor cell Anatomy 0.000 claims description 25
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims description 22
239000011230 binding agent Substances 0.000 claims description 22
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 21
DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 claims description 20
230000001747 exhibiting effect Effects 0.000 claims description 20
241000124008 Mammalia Species 0.000 claims description 19
238000002648 combination therapy Methods 0.000 claims description 19
239000002254 cytotoxic agent Substances 0.000 claims description 18
231100000599 cytotoxic agent Toxicity 0.000 claims description 18
239000003814 drug Substances 0.000 claims description 18
238000011282 treatment Methods 0.000 claims description 17
230000015572 biosynthetic process Effects 0.000 claims description 16
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
230000001965 increasing effect Effects 0.000 claims description 15
238000004393 prognosis Methods 0.000 claims description 15
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 claims description 14
239000000074 antisense oligonucleotide Substances 0.000 claims description 14
238000012230 antisense oligonucleotides Methods 0.000 claims description 14
HXCHCVDVKSCDHU-LULTVBGHSA-N calicheamicin Chemical compound C1[C@H](OC)[C@@H](NCC)CO[C@H]1O[C@H]1[C@H](O[C@@H]2C\3=C(NC(=O)OC)C(=O)C[C@](C/3=C/CSSSC)(O)C#C\C=C/C#C2)O[C@H](C)[C@@H](NO[C@@H]2O[C@H](C)[C@@H](SC(=O)C=3C(=C(OC)C(O[C@H]4[C@@H]([C@H](OC)[C@@H](O)[C@H](C)O4)O)=C(I)C=3C)OC)[C@@H](O)C2)[C@@H]1O HXCHCVDVKSCDHU-LULTVBGHSA-N 0.000 claims description 14
201000010099 disease Diseases 0.000 claims description 14
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 14
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 14
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 14
238000012360 testing method Methods 0.000 claims description 14
GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 claims description 13
229930195731 calicheamicin Natural products 0.000 claims description 13
239000003112 inhibitor Substances 0.000 claims description 13
230000002285 radioactive effect Effects 0.000 claims description 13
229930012538 Paclitaxel Natural products 0.000 claims description 12
229960001592 paclitaxel Drugs 0.000 claims description 12
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims description 11
108091034117 Oligonucleotide Proteins 0.000 claims description 11
239000003153 chemical reaction reagent Substances 0.000 claims description 11
229960004679 doxorubicin Drugs 0.000 claims description 11
229960000485 methotrexate Drugs 0.000 claims description 11
229960004528 vincristine Drugs 0.000 claims description 11
OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims description 11
102000004190 Enzymes Human genes 0.000 claims description 10
108090000790 Enzymes Proteins 0.000 claims description 10
150000002148 esters Chemical class 0.000 claims description 10
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 10
OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims description 10
UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 claims description 9
102100023181 Neurogenic locus notch homolog protein 1 Human genes 0.000 claims description 9
230000002829 reductive effect Effects 0.000 claims description 9
150000003839 salts Chemical class 0.000 claims description 9
108010006654 Bleomycin Proteins 0.000 claims description 8
108010092160 Dactinomycin Proteins 0.000 claims description 8
108700003486 Jagged-1 Proteins 0.000 claims description 8
102100032702 Protein jagged-1 Human genes 0.000 claims description 8
108700037966 Protein jagged-1 Proteins 0.000 claims description 8
OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 claims description 8
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims description 8
229960004316 cisplatin Drugs 0.000 claims description 8
VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 claims description 8
208000029824 high grade glioma Diseases 0.000 claims description 8
238000003064 k means clustering Methods 0.000 claims description 8
201000011614 malignant glioma Diseases 0.000 claims description 8
102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 7
108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 7
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims description 7
102100035857 Glutamate decarboxylase 2 Human genes 0.000 claims description 7
101000873786 Homo sapiens Glutamate decarboxylase 2 Proteins 0.000 claims description 7
101000979001 Homo sapiens Methionine aminopeptidase 2 Proteins 0.000 claims description 7
101000969087 Homo sapiens Microtubule-associated protein 2 Proteins 0.000 claims description 7
102100032733 Protein jagged-2 Human genes 0.000 claims description 7
101710170213 Protein jagged-2 Proteins 0.000 claims description 7
102000004243 Tubulin Human genes 0.000 claims description 7
108090000704 Tubulin Proteins 0.000 claims description 7
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 claims description 7
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 7
229960001561 bleomycin Drugs 0.000 claims description 7
229960004562 carboplatin Drugs 0.000 claims description 7
229960005243 carmustine Drugs 0.000 claims description 7
229960004397 cyclophosphamide Drugs 0.000 claims description 7
229960000684 cytarabine Drugs 0.000 claims description 7
229960000640 dactinomycin Drugs 0.000 claims description 7
229960005420 etoposide Drugs 0.000 claims description 7
229960002247 lomustine Drugs 0.000 claims description 7
238000002360 preparation method Methods 0.000 claims description 7
CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 claims description 7
229960000624 procarbazine Drugs 0.000 claims description 7
229930002330 retinoic acid Natural products 0.000 claims description 7
229960000303 topotecan Drugs 0.000 claims description 7
229960001727 tretinoin Drugs 0.000 claims description 7
101100162366 Caenorhabditis elegans akt-2 gene Proteins 0.000 claims description 6
102100021906 Cyclin-O Human genes 0.000 claims description 6
101100520033 Dictyostelium discoideum pikC gene Proteins 0.000 claims description 6
102100028260 Gamma-secretase subunit PEN-2 Human genes 0.000 claims description 6
101000901099 Homo sapiens Achaete-scute homolog 1 Proteins 0.000 claims description 6
101000897441 Homo sapiens Cyclin-O Proteins 0.000 claims description 6
101000579663 Homo sapiens Gamma-secretase subunit PEN-2 Proteins 0.000 claims description 6
101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 claims description 6
101000979249 Homo sapiens Neuromodulin Proteins 0.000 claims description 6
101000616502 Homo sapiens Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 Proteins 0.000 claims description 6
101001051706 Homo sapiens Ribosomal protein S6 kinase beta-1 Proteins 0.000 claims description 6
102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims description 6
102100023206 Neuromodulin Human genes 0.000 claims description 6
102100021797 Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 Human genes 0.000 claims description 6
101150096148 Psen2 gene Proteins 0.000 claims description 6
102100024908 Ribosomal protein S6 kinase beta-1 Human genes 0.000 claims description 6
102100030070 Serine/threonine-protein kinase Sgk1 Human genes 0.000 claims description 6
102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 claims description 6
BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 claims description 6
AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 claims description 6
208000036815 beta tubulin Diseases 0.000 claims description 6
230000003197 catalytic effect Effects 0.000 claims description 6
230000009918 complex formation Effects 0.000 claims description 6
NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 claims description 6
238000002376 fluorescence recovery after photobleaching Methods 0.000 claims description 6
239000003540 gamma secretase inhibitor Substances 0.000 claims description 6
229940084910 gliadel Drugs 0.000 claims description 6
CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 claims description 6
102000046701 nicastrin Human genes 0.000 claims description 6
108700022821 nicastrin Proteins 0.000 claims description 6
102000045246 noggin Human genes 0.000 claims description 6
108700007229 noggin Proteins 0.000 claims description 6
230000001293 nucleolytic effect Effects 0.000 claims description 6
229960003171 plicamycin Drugs 0.000 claims description 6
239000013074 reference sample Substances 0.000 claims description 6
230000001105 regulatory effect Effects 0.000 claims description 6
229960004964 temozolomide Drugs 0.000 claims description 6
239000005495 thyroid hormone Substances 0.000 claims description 6
229940036555 thyroid hormone Drugs 0.000 claims description 6
102000004217 thyroid hormone receptors Human genes 0.000 claims description 6
108090000721 thyroid hormone receptors Proteins 0.000 claims description 6
102000015534 trkB Receptor Human genes 0.000 claims description 6
108010064880 trkB Receptor Proteins 0.000 claims description 6
MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical compound [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 claims description 6
229960000604 valproic acid Drugs 0.000 claims description 6
101000864800 Homo sapiens Serine/threonine-protein kinase Sgk1 Proteins 0.000 claims description 5
239000012190 activator Substances 0.000 claims description 5
108010043671 prostatic acid phosphatase Proteins 0.000 claims description 5
102100022142 Achaete-scute homolog 1 Human genes 0.000 claims description 4
101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 claims description 4
102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 claims description 4
230000003115 biocidal effect Effects 0.000 claims description 4
230000034994 death Effects 0.000 claims description 4
230000004031 neuronal differentiation Effects 0.000 claims description 4
239000007787 solid Substances 0.000 claims description 4
101001120753 Homo sapiens Oligodendrocyte transcription factor 1 Proteins 0.000 claims description 3
102100026073 Oligodendrocyte transcription factor 1 Human genes 0.000 claims description 3
102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims description 3
238000001514 detection method Methods 0.000 claims description 3
230000007704 transition Effects 0.000 claims description 3
102100026882 Alpha-synuclein Human genes 0.000 claims 2
101100322915 Caenorhabditis elegans akt-1 gene Proteins 0.000 claims 2
101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 claims 2
101000688606 Homo sapiens Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 Proteins 0.000 claims 2
101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 2
101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 claims 2
101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims 2
102100021118 Microtubule-associated protein 2 Human genes 0.000 claims 2
101150098334 NOG gene Proteins 0.000 claims 2
101150115192 OLIG1 gene Proteins 0.000 claims 2
101150035190 PSEN1 gene Proteins 0.000 claims 2
102100024242 Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 Human genes 0.000 claims 2
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 2
VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 claims 2
UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 claims 2
ODIHLEYTPVYAPY-UHFFFAOYSA-N 3-[2-fluoro-4-[[3-[2-methyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methylamino]phenyl]propanoic acid Chemical compound CC1=CC(OCCCS(C)(=O)=O)=CC=C1C1=CC=CC(CNC=2C=C(F)C(CCC(O)=O)=CC=2)=C1 ODIHLEYTPVYAPY-UHFFFAOYSA-N 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 abstract description 78
108010070047 Notch Receptors Proteins 0.000 abstract description 35
102000005650 Notch Receptors Human genes 0.000 abstract description 35
230000037361 pathway Effects 0.000 abstract description 18
230000007730 Akt signaling Effects 0.000 abstract description 15
230000004913 activation Effects 0.000 abstract description 14
230000005913 Notch signaling pathway Effects 0.000 abstract description 6
210000004027 cell Anatomy 0.000 description 142
201000011510 cancer Diseases 0.000 description 72
108020004414 DNA Proteins 0.000 description 44
102000004169 proteins and genes Human genes 0.000 description 40
235000018102 proteins Nutrition 0.000 description 39
108060003951 Immunoglobulin Proteins 0.000 description 37
102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 37
102000018358 immunoglobulin Human genes 0.000 description 37
125000003275 alpha amino acid group Chemical group 0.000 description 27
208000005017 glioblastoma Diseases 0.000 description 27
206010003571 Astrocytoma Diseases 0.000 description 24
208000004104 gestational diabetes Diseases 0.000 description 24
239000011800 void material Substances 0.000 description 24
239000000562 conjugate Substances 0.000 description 22
230000035755 proliferation Effects 0.000 description 22
238000004519 manufacturing process Methods 0.000 description 21
102000039446 nucleic acids Human genes 0.000 description 21
108020004707 nucleic acids Proteins 0.000 description 21
102000005962 receptors Human genes 0.000 description 21
108020003175 receptors Proteins 0.000 description 21
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 20
102100039037 Vascular endothelial growth factor A Human genes 0.000 description 20
235000001014 amino acid Nutrition 0.000 description 20
230000000694 effects Effects 0.000 description 20
210000001178 neural stem cell Anatomy 0.000 description 20
239000002773 nucleotide Substances 0.000 description 20
125000003729 nucleotide group Chemical group 0.000 description 20
230000003068 static effect Effects 0.000 description 20
229940024606 amino acid Drugs 0.000 description 19
241001465754 Metazoa Species 0.000 description 18
230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 18
230000006870 function Effects 0.000 description 18
125000000539 amino acid group Chemical group 0.000 description 17
108010087819 Fc receptors Proteins 0.000 description 16
102000009109 Fc receptors Human genes 0.000 description 16
210000004556 brain Anatomy 0.000 description 16
210000004408 hybridoma Anatomy 0.000 description 16
230000011664 signaling Effects 0.000 description 16
150000001413 amino acids Chemical class 0.000 description 15
239000002246 antineoplastic agent Substances 0.000 description 14
230000000875 corresponding effect Effects 0.000 description 14
239000012636 effector Substances 0.000 description 14
238000002823 phage display Methods 0.000 description 14
102100038196 Chitinase-3-like protein 1 Human genes 0.000 description 13
230000033115 angiogenesis Effects 0.000 description 13
238000000338 in vitro Methods 0.000 description 13
238000001727 in vivo Methods 0.000 description 13
125000005647 linker group Chemical group 0.000 description 13
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 12
210000001519 tissue Anatomy 0.000 description 12
239000003053 toxin Substances 0.000 description 12
231100000765 toxin Toxicity 0.000 description 12
108700012359 toxins Proteins 0.000 description 12
241001529936 Murinae Species 0.000 description 11
150000001875 compounds Chemical class 0.000 description 11
239000002502 liposome Substances 0.000 description 11
239000000203 mixture Substances 0.000 description 11
230000008569 process Effects 0.000 description 11
230000002062 proliferating effect Effects 0.000 description 11
206010061818 Disease progression Diseases 0.000 description 10
238000003556 assay Methods 0.000 description 10
230000005750 disease progression Effects 0.000 description 10
239000003550 marker Substances 0.000 description 10
230000008685 targeting Effects 0.000 description 10
QWPXBEHQFHACTK-KZVYIGENSA-N (10e,12e)-86-chloro-12,14,4-trihydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-15,16-dihydro-14h-7-aza-1(6,4)-oxazina-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-6-one Chemical compound CN1C(=O)CC(O)C2(C)OC2C(C)C(OC(=O)N2)CC2(O)C(OC)\C=C\C=C(C)\CC2=CC(OC)=C(Cl)C1=C2 QWPXBEHQFHACTK-KZVYIGENSA-N 0.000 description 9
230000004071 biological effect Effects 0.000 description 9
230000000295 complement effect Effects 0.000 description 9
231100000433 cytotoxic Toxicity 0.000 description 9
230000001472 cytotoxic effect Effects 0.000 description 9
238000005516 engineering process Methods 0.000 description 9
230000004927 fusion Effects 0.000 description 9
229940127121 immunoconjugate Drugs 0.000 description 9
210000004129 prosencephalon Anatomy 0.000 description 9
238000011160 research Methods 0.000 description 9
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
206010035226 Plasma cell myeloma Diseases 0.000 description 8
230000004075 alteration Effects 0.000 description 8
238000013459 approach Methods 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
230000004540 complement-dependent cytotoxicity Effects 0.000 description 8
229940088598 enzyme Drugs 0.000 description 8
201000000050 myeloid neoplasm Diseases 0.000 description 8
230000004766 neurogenesis Effects 0.000 description 8
210000002569 neuron Anatomy 0.000 description 8
238000010837 poor prognosis Methods 0.000 description 8
239000002243 precursor Substances 0.000 description 8
230000004044 response Effects 0.000 description 8
239000000243 solution Substances 0.000 description 8
230000004614 tumor growth Effects 0.000 description 8
206010001488 Aggression Diseases 0.000 description 7
101000883515 Homo sapiens Chitinase-3-like protein 1 Proteins 0.000 description 7
241000699670 Mus sp. Species 0.000 description 7
108700037638 Neurogenic locus notch homolog protein 1 Proteins 0.000 description 7
108700020796 Oncogene Proteins 0.000 description 7
230000003321 amplification Effects 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
230000001588 bifunctional effect Effects 0.000 description 7
230000000903 blocking effect Effects 0.000 description 7
238000004113 cell culture Methods 0.000 description 7
238000003745 diagnosis Methods 0.000 description 7
229940079593 drug Drugs 0.000 description 7
238000009396 hybridization Methods 0.000 description 7
229940072221 immunoglobulins Drugs 0.000 description 7
108020004999 messenger RNA Proteins 0.000 description 7
230000035772 mutation Effects 0.000 description 7
238000003199 nucleic acid amplification method Methods 0.000 description 7
239000000047 product Substances 0.000 description 7
239000000126 substance Substances 0.000 description 7
102100032312 Brevican core protein Human genes 0.000 description 6
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 6
108010066813 Chitinase-3-Like Protein 1 Proteins 0.000 description 6
108091026890 Coding region Proteins 0.000 description 6
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 6
101000731086 Homo sapiens Brevican core protein Proteins 0.000 description 6
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
239000002253 acid Substances 0.000 description 6
239000003242 anti bacterial agent Substances 0.000 description 6
230000006907 apoptotic process Effects 0.000 description 6
230000030833 cell death Effects 0.000 description 6
238000004590 computer program Methods 0.000 description 6
125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 6
230000003013 cytotoxicity Effects 0.000 description 6
231100000135 cytotoxicity Toxicity 0.000 description 6
229940088597 hormone Drugs 0.000 description 6
239000005556 hormone Substances 0.000 description 6
230000005764 inhibitory process Effects 0.000 description 6
210000004498 neuroglial cell Anatomy 0.000 description 6
102000040430 polynucleotide Human genes 0.000 description 6
108091033319 polynucleotide Proteins 0.000 description 6
239000002157 polynucleotide Substances 0.000 description 6
230000009467 reduction Effects 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
230000019491 signal transduction Effects 0.000 description 6
238000006467 substitution reaction Methods 0.000 description 6
229960005486 vaccine Drugs 0.000 description 6
DGHHQBMTXTWTJV-BQAIUKQQSA-N 119413-54-6 Chemical compound Cl.C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 DGHHQBMTXTWTJV-BQAIUKQQSA-N 0.000 description 5
102000004127 Cytokines Human genes 0.000 description 5
108090000695 Cytokines Proteins 0.000 description 5
241000588724 Escherichia coli Species 0.000 description 5
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 5
208000037564 High-grade astrocytoma Diseases 0.000 description 5
QWPXBEHQFHACTK-UHFFFAOYSA-N Maytansinol Natural products CN1C(=O)CC(O)C2(C)OC2C(C)C(OC(=O)N2)CC2(O)C(OC)C=CC=C(C)CC2=CC(OC)=C(Cl)C1=C2 QWPXBEHQFHACTK-UHFFFAOYSA-N 0.000 description 5
206010027476 Metastases Diseases 0.000 description 5
102100023174 Methionine aminopeptidase 2 Human genes 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 5
108010039491 Ricin Proteins 0.000 description 5
241000283984 Rodentia Species 0.000 description 5
NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 5
102000040945 Transcription factor Human genes 0.000 description 5
108091023040 Transcription factor Proteins 0.000 description 5
YAYRGNWWLMLWJE-UHFFFAOYSA-L carboplatin Chemical compound O=C1O[Pt](N)(N)OC(=O)C11CCC1 YAYRGNWWLMLWJE-UHFFFAOYSA-L 0.000 description 5
238000011161 development Methods 0.000 description 5
230000018109 developmental process Effects 0.000 description 5
210000002889 endothelial cell Anatomy 0.000 description 5
238000010195 expression analysis Methods 0.000 description 5
229960002949 fluorouracil Drugs 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
230000002518 glial effect Effects 0.000 description 5
239000003102 growth factor Substances 0.000 description 5
239000001963 growth medium Substances 0.000 description 5
230000001900 immune effect Effects 0.000 description 5
150000002632 lipids Chemical class 0.000 description 5
230000036210 malignancy Effects 0.000 description 5
239000011159 matrix material Substances 0.000 description 5
230000009401 metastasis Effects 0.000 description 5
238000010208 microarray analysis Methods 0.000 description 5
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
238000012216 screening Methods 0.000 description 5
239000001509 sodium citrate Substances 0.000 description 5
230000009870 specific binding Effects 0.000 description 5
238000002560 therapeutic procedure Methods 0.000 description 5
VPFUWHKTPYPNGT-UHFFFAOYSA-N 3-(3,4-dihydroxyphenyl)-1-(5-hydroxy-2,2-dimethylchromen-6-yl)propan-1-one Chemical compound OC1=C2C=CC(C)(C)OC2=CC=C1C(=O)CCC1=CC=C(O)C(O)=C1 VPFUWHKTPYPNGT-UHFFFAOYSA-N 0.000 description 4
208000005623 Carcinogenesis Diseases 0.000 description 4
206010009944 Colon cancer Diseases 0.000 description 4
102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 description 4
201000010915 Glioblastoma multiforme Diseases 0.000 description 4
241000282412 Homo Species 0.000 description 4
101000891579 Homo sapiens Microtubule-associated protein tau Proteins 0.000 description 4
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 4
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 4
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 4
229930126263 Maytansine Natural products 0.000 description 4
102100040243 Microtubule-associated protein tau Human genes 0.000 description 4
241000283973 Oryctolagus cuniculus Species 0.000 description 4
102100033237 Pro-epidermal growth factor Human genes 0.000 description 4
108010022394 Threonine synthase Proteins 0.000 description 4
206010002224 anaplastic astrocytoma Diseases 0.000 description 4
230000002491 angiogenic effect Effects 0.000 description 4
229940088710 antibiotic agent Drugs 0.000 description 4
230000003140 astrocytic effect Effects 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
230000036952 cancer formation Effects 0.000 description 4
231100000504 carcinogenesis Toxicity 0.000 description 4
230000004663 cell proliferation Effects 0.000 description 4
230000008859 change Effects 0.000 description 4
210000000349 chromosome Anatomy 0.000 description 4
239000007822 coupling agent Substances 0.000 description 4
230000006378 damage Effects 0.000 description 4
102000004419 dihydrofolate reductase Human genes 0.000 description 4
238000011156 evaluation Methods 0.000 description 4
238000013467 fragmentation Methods 0.000 description 4
238000006062 fragmentation reaction Methods 0.000 description 4
210000004602 germ cell Anatomy 0.000 description 4
230000009036 growth inhibition Effects 0.000 description 4
125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
230000006872 improvement Effects 0.000 description 4
210000004698 lymphocyte Anatomy 0.000 description 4
WKPWGQKGSOKKOO-RSFHAFMBSA-N maytansine Chemical compound CO[C@@H]([C@@]1(O)C[C@](OC(=O)N1)([C@H]([C@@H]1O[C@@]1(C)[C@@H](OC(=O)[C@H](C)N(C)C(C)=O)CC(=O)N1C)C)[H])\C=C\C=C(C)\CC2=CC(OC)=C(Cl)C1=C2 WKPWGQKGSOKKOO-RSFHAFMBSA-N 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
239000012528 membrane Substances 0.000 description 4
210000003757 neuroblast Anatomy 0.000 description 4
239000002245 particle Substances 0.000 description 4
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 4
238000000746 purification Methods 0.000 description 4
238000012552 review Methods 0.000 description 4
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
239000007790 solid phase Substances 0.000 description 4
241000894007 species Species 0.000 description 4
208000024891 symptom Diseases 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
229940124597 therapeutic agent Drugs 0.000 description 4
WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 4
238000005406 washing Methods 0.000 description 4
JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 description 3
IEUUDEWWMRQUDS-UHFFFAOYSA-N (6-azaniumylidene-1,6-dimethoxyhexylidene)azanium;dichloride Chemical compound Cl.Cl.COC(=N)CCCCC(=N)OC IEUUDEWWMRQUDS-UHFFFAOYSA-N 0.000 description 3
VILFTWLXLYIEMV-UHFFFAOYSA-N 1,5-difluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC([N+]([O-])=O)=C(F)C=C1F VILFTWLXLYIEMV-UHFFFAOYSA-N 0.000 description 3
102100030390 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 Human genes 0.000 description 3
YBBNVCVOACOHIG-UHFFFAOYSA-N 2,2-diamino-1,4-bis(4-azidophenyl)-3-butylbutane-1,4-dione Chemical compound C=1C=C(N=[N+]=[N-])C=CC=1C(=O)C(N)(N)C(CCCC)C(=O)C1=CC=C(N=[N+]=[N-])C=C1 YBBNVCVOACOHIG-UHFFFAOYSA-N 0.000 description 3
STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 3
102000000412 Annexin Human genes 0.000 description 3
108050008874 Annexin Proteins 0.000 description 3
108020000948 Antisense Oligonucleotides Proteins 0.000 description 3
206010065869 Astrocytoma, low grade Diseases 0.000 description 3
102100035080 BDNF/NT-3 growth factors receptor Human genes 0.000 description 3
102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 3
206010006187 Breast cancer Diseases 0.000 description 3
208000026310 Breast neoplasm Diseases 0.000 description 3
102100031134 Docking protein 6 Human genes 0.000 description 3
102100040683 Fermitin family homolog 1 Human genes 0.000 description 3
102100028417 Fibroblast growth factor 12 Human genes 0.000 description 3
102100026561 Filamin-A Human genes 0.000 description 3
102100035924 Gamma-aminobutyric acid type B receptor subunit 2 Human genes 0.000 description 3
102100034339 Guanine nucleotide-binding protein G(olf) subunit alpha Human genes 0.000 description 3
101000583063 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 Proteins 0.000 description 3
101000596896 Homo sapiens BDNF/NT-3 growth factors receptor Proteins 0.000 description 3
101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 3
101000845687 Homo sapiens Docking protein 6 Proteins 0.000 description 3
101000892670 Homo sapiens Fermitin family homolog 1 Proteins 0.000 description 3
101000917234 Homo sapiens Fibroblast growth factor 12 Proteins 0.000 description 3
101000913549 Homo sapiens Filamin-A Proteins 0.000 description 3
101001000703 Homo sapiens Gamma-aminobutyric acid type B receptor subunit 2 Proteins 0.000 description 3
101000997083 Homo sapiens Guanine nucleotide-binding protein G(olf) subunit alpha Proteins 0.000 description 3
101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 3
101000613565 Homo sapiens PRKC apoptosis WT1 regulator protein Proteins 0.000 description 3
101001098116 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit gamma Proteins 0.000 description 3
101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 3
101000829541 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 13 Proteins 0.000 description 3
101001135402 Homo sapiens Prostaglandin-H2 D-isomerase Proteins 0.000 description 3
101001092185 Homo sapiens Regulator of cell cycle RGCC Proteins 0.000 description 3
101000777293 Homo sapiens Serine/threonine-protein kinase Chk1 Proteins 0.000 description 3
102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 3
102100032832 Integrin alpha-7 Human genes 0.000 description 3
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
102100024299 Maternal embryonic leucine zipper kinase Human genes 0.000 description 3
101710154611 Maternal embryonic leucine zipper kinase Proteins 0.000 description 3
206010029113 Neovascularisation Diseases 0.000 description 3
102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 3
102100040853 PRKC apoptosis WT1 regulator protein Human genes 0.000 description 3
102100037553 Phosphatidylinositol 3-kinase regulatory subunit gamma Human genes 0.000 description 3
102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
102100023209 Polypeptide N-acetylgalactosaminyltransferase 13 Human genes 0.000 description 3
102100033279 Prostaglandin-H2 D-isomerase Human genes 0.000 description 3
102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
102100035542 Regulator of cell cycle RGCC Human genes 0.000 description 3
230000018199 S phase Effects 0.000 description 3
102100031081 Serine/threonine-protein kinase Chk1 Human genes 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
102000007537 Type II DNA Topoisomerases Human genes 0.000 description 3
108010046308 Type II DNA Topoisomerases Proteins 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
230000009471 action Effects 0.000 description 3
230000003213 activating effect Effects 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
238000001042 affinity chromatography Methods 0.000 description 3
150000001299 aldehydes Chemical class 0.000 description 3
VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 3
239000002870 angiogenesis inducing agent Substances 0.000 description 3
230000000692 anti-sense effect Effects 0.000 description 3
230000000259 anti-tumor effect Effects 0.000 description 3
229940041181 antineoplastic drug Drugs 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000032823 cell division Effects 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
239000002738 chelating agent Substances 0.000 description 3
208000029742 colonic neoplasm Diseases 0.000 description 3
230000021615 conjugation Effects 0.000 description 3
239000000356 contaminant Substances 0.000 description 3
238000004132 cross linking Methods 0.000 description 3
230000001086 cytosolic effect Effects 0.000 description 3
STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
125000005442 diisocyanate group Chemical group 0.000 description 3
239000000539 dimer Substances 0.000 description 3
SLPJGDQJLTYWCI-UHFFFAOYSA-N dimethyl-(4,5,6,7-tetrabromo-1h-benzoimidazol-2-yl)-amine Chemical compound BrC1=C(Br)C(Br)=C2NC(N(C)C)=NC2=C1Br SLPJGDQJLTYWCI-UHFFFAOYSA-N 0.000 description 3
ZWIBGKZDAWNIFC-UHFFFAOYSA-N disuccinimidyl suberate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)CCC1=O ZWIBGKZDAWNIFC-UHFFFAOYSA-N 0.000 description 3
239000003623 enhancer Substances 0.000 description 3
230000007705 epithelial mesenchymal transition Effects 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
150000002222 fluorine compounds Chemical class 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
230000036541 health Effects 0.000 description 3
210000003958 hematopoietic stem cell Anatomy 0.000 description 3
150000002463 imidates Chemical class 0.000 description 3
230000003053 immunization Effects 0.000 description 3
238000002649 immunization Methods 0.000 description 3
230000016784 immunoglobulin production Effects 0.000 description 3
239000002596 immunotoxin Substances 0.000 description 3
230000002637 immunotoxin Effects 0.000 description 3
229940051026 immunotoxin Drugs 0.000 description 3
231100000608 immunotoxin Toxicity 0.000 description 3
230000008676 import Effects 0.000 description 3
108010092830 integrin alpha7beta1 Proteins 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
230000001404 mediated effect Effects 0.000 description 3
GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 3
238000002493 microarray Methods 0.000 description 3
230000000394 mitotic effect Effects 0.000 description 3
KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 3
230000003472 neutralizing effect Effects 0.000 description 3
230000002018 overexpression Effects 0.000 description 3
230000007170 pathology Effects 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
230000001737 promoting effect Effects 0.000 description 3
238000003156 radioimmunoprecipitation Methods 0.000 description 3
102000016914 ras Proteins Human genes 0.000 description 3
108010014186 ras Proteins Proteins 0.000 description 3
230000000306 recurrent effect Effects 0.000 description 3
210000002460 smooth muscle Anatomy 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
210000000130 stem cell Anatomy 0.000 description 3
229960001603 tamoxifen Drugs 0.000 description 3
238000002626 targeted therapy Methods 0.000 description 3
CNHYKKNIIGEXAY-UHFFFAOYSA-N thiolan-2-imine Chemical compound N=C1CCCS1 CNHYKKNIIGEXAY-UHFFFAOYSA-N 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
238000011269 treatment regimen Methods 0.000 description 3
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
210000003556 vascular endothelial cell Anatomy 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
OMJKFYKNWZZKTK-POHAHGRESA-N (5z)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide Chemical compound CN(C)N\N=C1/N=CN=C1C(N)=O OMJKFYKNWZZKTK-POHAHGRESA-N 0.000 description 2
TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical group COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 2
FZDFGHZZPBUTGP-UHFFFAOYSA-N 2-[[2-[bis(carboxymethyl)amino]-3-(4-isothiocyanatophenyl)propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(N(CC(O)=O)CC(O)=O)CC1=CC=C(N=C=S)C=C1 FZDFGHZZPBUTGP-UHFFFAOYSA-N 0.000 description 2
FBUTXZSKZCQABC-UHFFFAOYSA-N 2-amino-1-methyl-7h-purine-6-thione Chemical compound S=C1N(C)C(N)=NC2=C1NC=N2 FBUTXZSKZCQABC-UHFFFAOYSA-N 0.000 description 2
AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 description 2
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 2
GANZODCWZFAEGN-UHFFFAOYSA-N 5-mercapto-2-nitro-benzoic acid Chemical compound OC(=O)C1=CC(S)=CC=C1[N+]([O-])=O GANZODCWZFAEGN-UHFFFAOYSA-N 0.000 description 2
101150037123 APOE gene Proteins 0.000 description 2
101150095401 AURKA gene Proteins 0.000 description 2
108010066676 Abrin Proteins 0.000 description 2
102100034163 Alpha-actinin-1 Human genes 0.000 description 2
102100034608 Angiopoietin-2 Human genes 0.000 description 2
102100029470 Apolipoprotein E Human genes 0.000 description 2
206010003445 Ascites Diseases 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
101000669426 Aspergillus restrictus Ribonuclease mitogillin Proteins 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000972773 Aulopiformes Species 0.000 description 2
108090001008 Avidin Proteins 0.000 description 2
102100040535 BTB/POZ domain-containing protein KCTD4 Human genes 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
208000003174 Brain Neoplasms Diseases 0.000 description 2
102100024654 Calcitonin gene-related peptide type 1 receptor Human genes 0.000 description 2
101710158575 Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase Proteins 0.000 description 2
OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 2
102100032230 Caveolae-associated protein 1 Human genes 0.000 description 2
102100027047 Cell division control protein 6 homolog Human genes 0.000 description 2
102100033619 Cholesterol transporter ABCA5 Human genes 0.000 description 2
102100022145 Collagen alpha-1(IV) chain Human genes 0.000 description 2
102100033781 Collagen alpha-2(IV) chain Human genes 0.000 description 2
102000007644 Colony-Stimulating Factors Human genes 0.000 description 2
108010071942 Colony-Stimulating Factors Proteins 0.000 description 2
108010047041 Complementarity Determining Regions Proteins 0.000 description 2
108091035707 Consensus sequence Proteins 0.000 description 2
102100024326 Contactin-1 Human genes 0.000 description 2
108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 description 2
108700032819 Croton tiglium crotin II Proteins 0.000 description 2
XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 2
108050006400 Cyclin Proteins 0.000 description 2
108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 2
230000004544 DNA amplification Effects 0.000 description 2
108010053770 Deoxyribonucleases Proteins 0.000 description 2
102000016911 Deoxyribonucleases Human genes 0.000 description 2
102000016607 Diphtheria Toxin Human genes 0.000 description 2
108010053187 Diphtheria Toxin Proteins 0.000 description 2
102100037713 Down syndrome cell adhesion molecule Human genes 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
102000001301 EGF receptor Human genes 0.000 description 2
108060006698 EGF receptor Proteins 0.000 description 2
102100032038 EH domain-containing protein 3 Human genes 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
102100036448 Endothelial PAS domain-containing protein 1 Human genes 0.000 description 2
102100030779 Ephrin type-B receptor 1 Human genes 0.000 description 2
HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 description 2
102000003951 Erythropoietin Human genes 0.000 description 2
108090000394 Erythropoietin Proteins 0.000 description 2
229930189413 Esperamicin Natural products 0.000 description 2
101710082714 Exotoxin A Proteins 0.000 description 2
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 2
102100031706 Fibroblast growth factor 1 Human genes 0.000 description 2
241000724791 Filamentous phage Species 0.000 description 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
102000012673 Follicle Stimulating Hormone Human genes 0.000 description 2
108010079345 Follicle Stimulating Hormone Proteins 0.000 description 2
102100028121 Fos-related antigen 2 Human genes 0.000 description 2
102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 2
108700004714 Gelonium multiflorum GEL Proteins 0.000 description 2
102100030651 Glutamate receptor 2 Human genes 0.000 description 2
ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
208000031886 HIV Infections Diseases 0.000 description 2
208000037357 HIV infectious disease Diseases 0.000 description 2
102100039990 Hairy/enhancer-of-split related with YRPW motif protein 2 Human genes 0.000 description 2
101000799406 Homo sapiens Alpha-actinin-1 Proteins 0.000 description 2
101000924533 Homo sapiens Angiopoietin-2 Proteins 0.000 description 2
101000613899 Homo sapiens BTB/POZ domain-containing protein KCTD4 Proteins 0.000 description 2
101000760563 Homo sapiens Calcitonin gene-related peptide type 1 receptor Proteins 0.000 description 2
101000869049 Homo sapiens Caveolae-associated protein 1 Proteins 0.000 description 2
101000914465 Homo sapiens Cell division control protein 6 homolog Proteins 0.000 description 2
101000880512 Homo sapiens Centromere protein U Proteins 0.000 description 2
101000801660 Homo sapiens Cholesterol transporter ABCA5 Proteins 0.000 description 2
101000901150 Homo sapiens Collagen alpha-1(IV) chain Proteins 0.000 description 2
101000710876 Homo sapiens Collagen alpha-2(IV) chain Proteins 0.000 description 2
101000909520 Homo sapiens Contactin-1 Proteins 0.000 description 2
101000880945 Homo sapiens Down syndrome cell adhesion molecule Proteins 0.000 description 2
101001064150 Homo sapiens Ephrin type-B receptor 1 Proteins 0.000 description 2
101001059934 Homo sapiens Fos-related antigen 2 Proteins 0.000 description 2
101000868643 Homo sapiens G2/mitotic-specific cyclin-B1 Proteins 0.000 description 2
101000616435 Homo sapiens Gamma-sarcoglycan Proteins 0.000 description 2
101001010449 Homo sapiens Glutamate receptor 2 Proteins 0.000 description 2
101001035089 Homo sapiens Hairy/enhancer-of-split related with YRPW motif protein 2 Proteins 0.000 description 2
101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 description 2
101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 2
101000614618 Homo sapiens Junctophilin-3 Proteins 0.000 description 2
101001008949 Homo sapiens Kinesin-like protein KIF14 Proteins 0.000 description 2
101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 2
101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 2
101000951325 Homo sapiens Mitoferrin-1 Proteins 0.000 description 2
101000929834 Homo sapiens Monoacylglycerol lipase ABHD6 Proteins 0.000 description 2
101001109470 Homo sapiens NKG2-E type II integral membrane protein Proteins 0.000 description 2
101000655246 Homo sapiens Neutral amino acid transporter A Proteins 0.000 description 2
101000585555 Homo sapiens PCNA-associated factor Proteins 0.000 description 2
101000595746 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Proteins 0.000 description 2
101000983166 Homo sapiens Phospholipase A2 group V Proteins 0.000 description 2
101000662592 Homo sapiens Poly [ADP-ribose] polymerase tankyrase-2 Proteins 0.000 description 2
101001062754 Homo sapiens Protein FAM13C Proteins 0.000 description 2
101000995300 Homo sapiens Protein NDRG2 Proteins 0.000 description 2
101000789800 Homo sapiens Protein YIPF3 Proteins 0.000 description 2
101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
101000823237 Homo sapiens Reticulon-1 Proteins 0.000 description 2
101000617796 Homo sapiens SPARC-related modular calcium-binding protein 1 Proteins 0.000 description 2
101000688543 Homo sapiens Shugoshin 2 Proteins 0.000 description 2
101000825726 Homo sapiens Structural maintenance of chromosomes protein 4 Proteins 0.000 description 2
101000763314 Homo sapiens Thrombomodulin Proteins 0.000 description 2
101000837626 Homo sapiens Thyroid hormone receptor alpha Proteins 0.000 description 2
101000642517 Homo sapiens Transcription factor SOX-6 Proteins 0.000 description 2
101000579613 Homo sapiens U6 snRNA-associated Sm-like protein LSm5 Proteins 0.000 description 2
101000760337 Homo sapiens Urokinase plasminogen activator surface receptor Proteins 0.000 description 2
101000797207 Homo sapiens tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 Proteins 0.000 description 2
108010000521 Human Growth Hormone Proteins 0.000 description 2
102000002265 Human Growth Hormone Human genes 0.000 description 2
239000000854 Human Growth Hormone Substances 0.000 description 2
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 2
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 2
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
102100029571 Immunoglobulin J chain Human genes 0.000 description 2
102000013463 Immunoglobulin Light Chains Human genes 0.000 description 2
108010065825 Immunoglobulin Light Chains Proteins 0.000 description 2
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
108010063738 Interleukins Proteins 0.000 description 2
102000015696 Interleukins Human genes 0.000 description 2
ZCYVEMRRCGMTRW-AHCXROLUSA-N Iodine-123 Chemical compound [123I] ZCYVEMRRCGMTRW-AHCXROLUSA-N 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
102100040488 Junctophilin-3 Human genes 0.000 description 2
102100027631 Kinesin-like protein KIF14 Human genes 0.000 description 2
102100020880 Kit ligand Human genes 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
239000005551 L01XE03 - Erlotinib Substances 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 2
102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 2
102000009151 Luteinizing Hormone Human genes 0.000 description 2
108010073521 Luteinizing Hormone Proteins 0.000 description 2
102000004137 Lysophosphatidic Acid Receptors Human genes 0.000 description 2
108090000642 Lysophosphatidic Acid Receptors Proteins 0.000 description 2
230000027311 M phase Effects 0.000 description 2
101710125418 Major capsid protein Proteins 0.000 description 2
102000029749 Microtubule Human genes 0.000 description 2
108091022875 Microtubule Proteins 0.000 description 2
102100037984 Mitoferrin-1 Human genes 0.000 description 2
244000302512 Momordica charantia Species 0.000 description 2
235000009811 Momordica charantia Nutrition 0.000 description 2
102100035912 Monoacylglycerol lipase ABHD6 Human genes 0.000 description 2
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 2
WTBIAPVQQBCLFP-UHFFFAOYSA-N N.N.N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O Chemical compound N.N.N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O WTBIAPVQQBCLFP-UHFFFAOYSA-N 0.000 description 2
101150065403 NECTIN2 gene Proteins 0.000 description 2
102100022701 NKG2-E type II integral membrane protein Human genes 0.000 description 2
238000005481 NMR spectroscopy Methods 0.000 description 2
206010028851 Necrosis Diseases 0.000 description 2
102100035488 Nectin-2 Human genes 0.000 description 2
201000010133 Oligodendroglioma Diseases 0.000 description 2
102100029879 PCNA-associated factor Human genes 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
102100036056 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Human genes 0.000 description 2
102100026832 Phospholipase A2 group V Human genes 0.000 description 2
101100413173 Phytolacca americana PAP2 gene Proteins 0.000 description 2
108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 2
102100037477 Poly [ADP-ribose] polymerase tankyrase-2 Human genes 0.000 description 2
102100036691 Proliferating cell nuclear antigen Human genes 0.000 description 2
102100030559 Protein FAM13C Human genes 0.000 description 2
102100034436 Protein NDRG2 Human genes 0.000 description 2
108010076504 Protein Sorting Signals Proteins 0.000 description 2
102100028077 Protein YIPF3 Human genes 0.000 description 2
241000589517 Pseudomonas aeruginosa Species 0.000 description 2
238000011529 RT qPCR Methods 0.000 description 2
241000700159 Rattus Species 0.000 description 2
102100022647 Reticulon-1 Human genes 0.000 description 2
102100038042 Retinoblastoma-associated protein Human genes 0.000 description 2
102100025373 Runt-related transcription factor 1 Human genes 0.000 description 2
108091006629 SLC13A2 Proteins 0.000 description 2
102000012978 SLC1A4 Human genes 0.000 description 2
102100021995 SPARC-related modular calcium-binding protein 1 Human genes 0.000 description 2
102100024238 Shugoshin 2 Human genes 0.000 description 2
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
101150043341 Socs3 gene Proteins 0.000 description 2
108010039445 Stem Cell Factor Proteins 0.000 description 2
102100022842 Structural maintenance of chromosomes protein 4 Human genes 0.000 description 2
108700027337 Suppressor of Cytokine Signaling 3 Proteins 0.000 description 2
102100024283 Suppressor of cytokine signaling 3 Human genes 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 2
229940123237 Taxane Drugs 0.000 description 2
241001116498 Taxus baccata Species 0.000 description 2
FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 2
102100026966 Thrombomodulin Human genes 0.000 description 2
102000036693 Thrombopoietin Human genes 0.000 description 2
108010041111 Thrombopoietin Proteins 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
102100028702 Thyroid hormone receptor alpha Human genes 0.000 description 2
102000011923 Thyrotropin Human genes 0.000 description 2
108010061174 Thyrotropin Proteins 0.000 description 2
102100036694 Transcription factor SOX-6 Human genes 0.000 description 2
108010009583 Transforming Growth Factors Proteins 0.000 description 2
102000009618 Transforming Growth Factors Human genes 0.000 description 2
108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
102100028261 U6 snRNA-associated Sm-like protein LSm5 Human genes 0.000 description 2
102100024689 Urokinase plasminogen activator surface receptor Human genes 0.000 description 2
240000001866 Vernicia fordii Species 0.000 description 2
JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 2
VWQVUPCCIRVNHF-OUBTZVSYSA-N Yttrium-90 Chemical compound [90Y] VWQVUPCCIRVNHF-OUBTZVSYSA-N 0.000 description 2
230000035508 accumulation Effects 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
230000036982 action potential Effects 0.000 description 2
230000016571 aggressive behavior Effects 0.000 description 2
208000012761 aggressive behavior Diseases 0.000 description 2
108010001818 alpha-sarcin Proteins 0.000 description 2
ROBVIMPUHSLWNV-UHFFFAOYSA-N aminoglutethimide Chemical compound C=1C=C(N)C=CC=1C1(CC)CCC(=O)NC1=O ROBVIMPUHSLWNV-UHFFFAOYSA-N 0.000 description 2
229960003437 aminoglutethimide Drugs 0.000 description 2
229960003896 aminopterin Drugs 0.000 description 2
238000010171 animal model Methods 0.000 description 2
239000003817 anthracycline antibiotic agent Substances 0.000 description 2
230000001093 anti-cancer Effects 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
210000001130 astrocyte Anatomy 0.000 description 2
230000003376 axonal effect Effects 0.000 description 2
210000003719 b-lymphocyte Anatomy 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000006399 behavior Effects 0.000 description 2
QZPQTZZNNJUOLS-UHFFFAOYSA-N beta-lapachone Chemical compound C12=CC=CC=C2C(=O)C(=O)C2=C1OC(C)(C)CC2 QZPQTZZNNJUOLS-UHFFFAOYSA-N 0.000 description 2
230000031018 biological processes and functions Effects 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
230000004641 brain development Effects 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
238000004422 calculation algorithm Methods 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
239000000969 carrier Substances 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
238000012412 chemical coupling Methods 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
229940047120 colony stimulating factors Drugs 0.000 description 2
230000024203 complement activation Effects 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
239000003431 cross linking reagent Substances 0.000 description 2
NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
235000018417 cysteine Nutrition 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
239000000824 cytostatic agent Substances 0.000 description 2
230000001085 cytostatic effect Effects 0.000 description 2
229960003901 dacarbazine Drugs 0.000 description 2
229960000975 daunorubicin Drugs 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
229960000633 dextran sulfate Drugs 0.000 description 2
229930191339 dianthin Natural products 0.000 description 2
AFZSMODLJJCVPP-UHFFFAOYSA-N dibenzothiazol-2-yl disulfide Chemical compound C1=CC=C2SC(SSC=3SC4=CC=CC=C4N=3)=NC2=C1 AFZSMODLJJCVPP-UHFFFAOYSA-N 0.000 description 2
230000029087 digestion Effects 0.000 description 2
238000006471 dimerization reaction Methods 0.000 description 2
206010013023 diphtheria Diseases 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
150000004662 dithiols Chemical class 0.000 description 2
229960003668 docetaxel Drugs 0.000 description 2
230000003828 downregulation Effects 0.000 description 2
230000009977 dual effect Effects 0.000 description 2
108010018033 endothelial PAS domain-containing protein 1 Proteins 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
108010028531 enomycin Proteins 0.000 description 2
229960001904 epirubicin Drugs 0.000 description 2
AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 2
229940105423 erythropoietin Drugs 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
210000003754 fetus Anatomy 0.000 description 2
238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
238000002509 fluorescent in situ hybridization Methods 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
229940028334 follicle stimulating hormone Drugs 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
CHPZKNULDCNCBW-UHFFFAOYSA-N gallium nitrate Chemical compound [Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O CHPZKNULDCNCBW-UHFFFAOYSA-N 0.000 description 2
230000037442 genomic alteration Effects 0.000 description 2
108010037896 heparin-binding hemagglutinin Proteins 0.000 description 2
230000002962 histologic effect Effects 0.000 description 2
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
229960001101 ifosfamide Drugs 0.000 description 2
HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 2
239000012642 immune effector Substances 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
238000003364 immunohistochemistry Methods 0.000 description 2
229940121354 immunomodulator Drugs 0.000 description 2
230000001976 improved effect Effects 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
230000008595 infiltration Effects 0.000 description 2
238000001764 infiltration Methods 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000003993 interaction Effects 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
229940047122 interleukins Drugs 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
238000011835 investigation Methods 0.000 description 2
GURKHSYORGJETM-WAQYZQTGSA-N irinotecan hydrochloride (anhydrous) Chemical compound Cl.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 GURKHSYORGJETM-WAQYZQTGSA-N 0.000 description 2
238000002955 isolation Methods 0.000 description 2
201000000573 juvenile pilocytic astrocytoma Diseases 0.000 description 2
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
230000003902 lesion Effects 0.000 description 2
229960004338 leuprorelin Drugs 0.000 description 2
208000022080 low-grade astrocytoma Diseases 0.000 description 2
229940040129 luteinizing hormone Drugs 0.000 description 2
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
239000000463 material Substances 0.000 description 2
HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 2
229960004961 mechlorethamine Drugs 0.000 description 2
239000002609 medium Substances 0.000 description 2
229960001428 mercaptopurine Drugs 0.000 description 2
TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
210000004688 microtubule Anatomy 0.000 description 2
229960001156 mitoxantrone Drugs 0.000 description 2
108010010621 modeccin Proteins 0.000 description 2
210000001616 monocyte Anatomy 0.000 description 2
230000000877 morphologic effect Effects 0.000 description 2
210000000822 natural killer cell Anatomy 0.000 description 2
230000017074 necrotic cell death Effects 0.000 description 2
QZGIWPZCWHMVQL-UIYAJPBUSA-N neocarzinostatin chromophore Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1O[C@@H]1C/2=C/C#C[C@H]3O[C@@]3([C@@H]3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12 QZGIWPZCWHMVQL-UIYAJPBUSA-N 0.000 description 2
230000009826 neoplastic cell growth Effects 0.000 description 2
230000001613 neoplastic effect Effects 0.000 description 2
210000000440 neutrophil Anatomy 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
210000001672 ovary Anatomy 0.000 description 2
DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 2
229960001756 oxaliplatin Drugs 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
239000012071 phase Substances 0.000 description 2
108010076042 phenomycin Proteins 0.000 description 2
150000003904 phospholipids Chemical class 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
238000003752 polymerase chain reaction Methods 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
235000019833 protease Nutrition 0.000 description 2
238000000159 protein binding assay Methods 0.000 description 2
230000005180 public health Effects 0.000 description 2
RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
229960004622 raloxifene Drugs 0.000 description 2
238000003259 recombinant expression Methods 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
235000019515 salmon Nutrition 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
230000028327 secretion Effects 0.000 description 2
229940095743 selective estrogen receptor modulator Drugs 0.000 description 2
239000000333 selective estrogen receptor modulator Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
239000004332 silver Substances 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
239000001488 sodium phosphate Substances 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
210000000278 spinal cord Anatomy 0.000 description 2
238000009987 spinning Methods 0.000 description 2
PVYJZLYGTZKPJE-UHFFFAOYSA-N streptonigrin Chemical compound C=1C=C2C(=O)C(OC)=C(N)C(=O)C2=NC=1C(C=1N)=NC(C(O)=O)=C(C)C=1C1=CC=C(OC)C(OC)=C1O PVYJZLYGTZKPJE-UHFFFAOYSA-N 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
230000005062 synaptic transmission Effects 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
102100032968 tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 Human genes 0.000 description 2
229940063683 taxotere Drugs 0.000 description 2
230000004797 therapeutic response Effects 0.000 description 2
125000000101 thioether group Chemical group 0.000 description 2
229960001196 thiotepa Drugs 0.000 description 2
229960003087 tioguanine Drugs 0.000 description 2
238000012546 transfer Methods 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
230000014616 translation Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 2
229960003048 vinblastine Drugs 0.000 description 2
229960004355 vindesine Drugs 0.000 description 2
229960004276 zoledronic acid Drugs 0.000 description 2
NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 1
WDQLRUYAYXDIFW-RWKIJVEZSA-N (2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 WDQLRUYAYXDIFW-RWKIJVEZSA-N 0.000 description 1
YXTKHLHCVFUPPT-YYFJYKOTSA-N (2s)-2-[[4-[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;(1r,2r)-1,2-dimethanidylcyclohexane;5-fluoro-1h-pyrimidine-2,4-dione;oxalic acid;platinum(2+) Chemical compound [Pt+2].OC(=O)C(O)=O.[CH2-][C@@H]1CCCC[C@H]1[CH2-].FC1=CNC(=O)NC1=O.C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 YXTKHLHCVFUPPT-YYFJYKOTSA-N 0.000 description 1
FLWWDYNPWOSLEO-HQVZTVAUSA-N (2s)-2-[[4-[1-(2-amino-4-oxo-1h-pteridin-6-yl)ethyl-methylamino]benzoyl]amino]pentanedioic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1C(C)N(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FLWWDYNPWOSLEO-HQVZTVAUSA-N 0.000 description 1
OOIBFPKQHULHSQ-UHFFFAOYSA-N (3-hydroxy-1-adamantyl) 2-methylprop-2-enoate Chemical compound C1C(C2)CC3CC2(O)CC1(OC(=O)C(=C)C)C3 OOIBFPKQHULHSQ-UHFFFAOYSA-N 0.000 description 1
CGMTUJFWROPELF-YPAAEMCBSA-N (3E,5S)-5-[(2S)-butan-2-yl]-3-(1-hydroxyethylidene)pyrrolidine-2,4-dione Chemical compound CC[C@H](C)[C@@H]1NC(=O)\C(=C(/C)O)C1=O CGMTUJFWROPELF-YPAAEMCBSA-N 0.000 description 1
TVIRNGFXQVMMGB-OFWIHYRESA-N (3s,6r,10r,13e,16s)-16-[(2r,3r,4s)-4-chloro-3-hydroxy-4-phenylbutan-2-yl]-10-[(3-chloro-4-methoxyphenyl)methyl]-6-methyl-3-(2-methylpropyl)-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone Chemical compound C1=C(Cl)C(OC)=CC=C1C[C@@H]1C(=O)NC[C@@H](C)C(=O)O[C@@H](CC(C)C)C(=O)O[C@H]([C@H](C)[C@@H](O)[C@@H](Cl)C=2C=CC=CC=2)C/C=C/C(=O)N1 TVIRNGFXQVMMGB-OFWIHYRESA-N 0.000 description 1
XRBSKUSTLXISAB-XVVDYKMHSA-N (5r,6r,7r,8r)-8-hydroxy-7-(hydroxymethyl)-5-(3,4,5-trimethoxyphenyl)-5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxole-6-carboxylic acid Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H](CO)[C@@H]2C(O)=O)=C1 XRBSKUSTLXISAB-XVVDYKMHSA-N 0.000 description 1
XRBSKUSTLXISAB-UHFFFAOYSA-N (7R,7'R,8R,8'R)-form-Podophyllic acid Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C(CO)C2C(O)=O)=C1 XRBSKUSTLXISAB-UHFFFAOYSA-N 0.000 description 1
AESVUZLWRXEGEX-DKCAWCKPSA-N (7S,9R)-7-[(2S,4R,5R,6R)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione iron(3+) Chemical compound [Fe+3].COc1cccc2C(=O)c3c(O)c4C[C@@](O)(C[C@H](O[C@@H]5C[C@@H](N)[C@@H](O)[C@@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO AESVUZLWRXEGEX-DKCAWCKPSA-N 0.000 description 1
JXVAMODRWBNUSF-KZQKBALLSA-N (7s,9r,10r)-7-[(2r,4s,5s,6s)-5-[[(2s,4as,5as,7s,9s,9ar,10ar)-2,9-dimethyl-3-oxo-4,4a,5a,6,7,9,9a,10a-octahydrodipyrano[4,2-a:4',3'-e][1,4]dioxin-7-yl]oxy]-4-(dimethylamino)-6-methyloxan-2-yl]oxy-10-[(2s,4s,5s,6s)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2 Chemical compound O([C@@H]1C2=C(O)C=3C(=O)C4=CC=CC(O)=C4C(=O)C=3C(O)=C2[C@@H](O[C@@H]2O[C@@H](C)[C@@H](O[C@@H]3O[C@@H](C)[C@H]4O[C@@H]5O[C@@H](C)C(=O)C[C@@H]5O[C@H]4C3)[C@H](C2)N(C)C)C[C@]1(O)CC)[C@H]1C[C@H](N(C)C)[C@H](O)[C@H](C)O1 JXVAMODRWBNUSF-KZQKBALLSA-N 0.000 description 1
INAUWOVKEZHHDM-PEDBPRJASA-N (7s,9s)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[(2r,4s,5s,6s)-5-hydroxy-6-methyl-4-morpholin-4-yloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride Chemical compound Cl.N1([C@H]2C[C@@H](O[C@@H](C)[C@H]2O)O[C@H]2C[C@@](O)(CC=3C(O)=C4C(=O)C=5C=CC=C(C=5C(=O)C4=C(O)C=32)OC)C(=O)CO)CCOCC1 INAUWOVKEZHHDM-PEDBPRJASA-N 0.000 description 1
RCFNNLSZHVHCEK-IMHLAKCZSA-N (7s,9s)-7-(4-amino-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride Chemical compound [Cl-].O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)C1CC([NH3+])CC(C)O1 RCFNNLSZHVHCEK-IMHLAKCZSA-N 0.000 description 1
NOPNWHSMQOXAEI-PUCKCBAPSA-N (7s,9s)-7-[(2r,4s,5s,6s)-4-(2,3-dihydropyrrol-1-yl)-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione Chemical compound N1([C@H]2C[C@@H](O[C@@H](C)[C@H]2O)O[C@H]2C[C@@](O)(CC=3C(O)=C4C(=O)C=5C=CC=C(C=5C(=O)C4=C(O)C=32)OC)C(=O)CO)CCC=C1 NOPNWHSMQOXAEI-PUCKCBAPSA-N 0.000 description 1
FPVKHBSQESCIEP-UHFFFAOYSA-N (8S)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol Natural products C1C(O)C(CO)OC1N1C(NC=NCC2O)=C2N=C1 FPVKHBSQESCIEP-UHFFFAOYSA-N 0.000 description 1
IEXUMDBQLIVNHZ-YOUGDJEHSA-N (8s,11r,13r,14s,17s)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(O)CCCO)[C@@]2(C)C1 IEXUMDBQLIVNHZ-YOUGDJEHSA-N 0.000 description 1
LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 description 1
AGNGYMCLFWQVGX-AGFFZDDWSA-N (e)-1-[(2s)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 description 1
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
FJQZXCPWAGYPSD-UHFFFAOYSA-N 1,3,4,6-tetrachloro-3a,6a-diphenylimidazo[4,5-d]imidazole-2,5-dione Chemical compound ClN1C(=O)N(Cl)C2(C=3C=CC=CC=3)N(Cl)C(=O)N(Cl)C12C1=CC=CC=C1 FJQZXCPWAGYPSD-UHFFFAOYSA-N 0.000 description 1
FONKWHRXTPJODV-DNQXCXABSA-N 1,3-bis[2-[(8s)-8-(chloromethyl)-4-hydroxy-1-methyl-7,8-dihydro-3h-pyrrolo[3,2-e]indole-6-carbonyl]-1h-indol-5-yl]urea Chemical compound C1([C@H](CCl)CN2C(=O)C=3NC4=CC=C(C=C4C=3)NC(=O)NC=3C=C4C=C(NC4=CC=3)C(=O)N3C4=CC(O)=C5NC=C(C5=C4[C@H](CCl)C3)C)=C2C=C(O)C2=C1C(C)=CN2 FONKWHRXTPJODV-DNQXCXABSA-N 0.000 description 1
WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
MYBLAOJMRYYKMS-RTRLPJTCSA-N 1-(2-chloroethyl)-1-nitroso-3-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea Chemical compound OC[C@H]1OC(O)[C@H](NC(=O)N(CCCl)N=O)[C@@H](O)[C@@H]1O MYBLAOJMRYYKMS-RTRLPJTCSA-N 0.000 description 1
MQLACMBJVPINKE-UHFFFAOYSA-N 10-[(3-hydroxy-4-methoxyphenyl)methylidene]anthracen-9-one Chemical compound C1=C(O)C(OC)=CC=C1C=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MQLACMBJVPINKE-UHFFFAOYSA-N 0.000 description 1
PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 1
BTOTXLJHDSNXMW-POYBYMJQSA-N 2,3-dideoxyuridine Chemical compound O1[C@H](CO)CC[C@@H]1N1C(=O)NC(=O)C=C1 BTOTXLJHDSNXMW-POYBYMJQSA-N 0.000 description 1
BOMZMNZEXMAQQW-UHFFFAOYSA-N 2,5,11-trimethyl-6h-pyrido[4,3-b]carbazol-2-ium-9-ol;acetate Chemical compound CC([O-])=O.C[N+]1=CC=C2C(C)=C(NC=3C4=CC(O)=CC=3)C4=C(C)C2=C1 BOMZMNZEXMAQQW-UHFFFAOYSA-N 0.000 description 1
FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
QCXJFISCRQIYID-IAEPZHFASA-N 2-amino-1-n-[(3s,6s,7r,10s,16s)-3-[(2s)-butan-2-yl]-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-10-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-9-n-[(3s,6s,7r,10s,16s)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propa Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N=C2C(C(=O)N[C@@H]3C(=O)N[C@H](C(N4CCC[C@H]4C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]3C)=O)[C@@H](C)CC)=C(N)C(=O)C(C)=C2O2)C2=C(C)C=C1 QCXJFISCRQIYID-IAEPZHFASA-N 0.000 description 1
DIDGPCDGNMIUNX-UUOKFMHZSA-N 2-amino-9-[(2r,3r,4s,5r)-5-(dihydroxyphosphinothioyloxymethyl)-3,4-dihydroxyoxolan-2-yl]-3h-purin-6-one Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=S)[C@@H](O)[C@H]1O DIDGPCDGNMIUNX-UUOKFMHZSA-N 0.000 description 1
VNBAOSVONFJBKP-UHFFFAOYSA-N 2-chloro-n,n-bis(2-chloroethyl)propan-1-amine;hydrochloride Chemical compound Cl.CC(Cl)CN(CCCl)CCCl VNBAOSVONFJBKP-UHFFFAOYSA-N 0.000 description 1
102100024824 3 beta-hydroxysteroid dehydrogenase type 7 Human genes 0.000 description 1
YIMDLWDNDGKDTJ-QLKYHASDSA-N 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin Chemical compound N1([C@H]2C[C@@H](O[C@@H](C)[C@H]2O)O[C@H]2C[C@@](O)(CC=3C(O)=C4C(=O)C=5C=CC=C(C=5C(=O)C4=C(O)C=32)OC)C(=O)CO)CCOCC1C#N YIMDLWDNDGKDTJ-QLKYHASDSA-N 0.000 description 1
NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 description 1
PWMYMKOUNYTVQN-UHFFFAOYSA-N 3-(8,8-diethyl-2-aza-8-germaspiro[4.5]decan-2-yl)-n,n-dimethylpropan-1-amine Chemical compound C1C[Ge](CC)(CC)CCC11CN(CCCN(C)C)CC1 PWMYMKOUNYTVQN-UHFFFAOYSA-N 0.000 description 1
QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
CLPFFLWZZBQMAO-UHFFFAOYSA-N 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile Chemical compound C1=CC(C#N)=CC=C1C1N2C=NC=C2CCC1 CLPFFLWZZBQMAO-UHFFFAOYSA-N 0.000 description 1
DODQJNMQWMSYGS-QPLCGJKRSA-N 4-[(z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 DODQJNMQWMSYGS-QPLCGJKRSA-N 0.000 description 1
NCQDNRMSPJIZKR-UHFFFAOYSA-N 4-[[1-(2,5-dioxopyrrolidin-1-yl)-2h-pyridin-2-yl]sulfanyl]pentanoic acid Chemical compound OC(=O)CCC(C)SC1C=CC=CN1N1C(=O)CCC1=O NCQDNRMSPJIZKR-UHFFFAOYSA-N 0.000 description 1
IDPUKCWIGUEADI-UHFFFAOYSA-N 5-[bis(2-chloroethyl)amino]uracil Chemical compound ClCCN(CCCl)C1=CNC(=O)NC1=O IDPUKCWIGUEADI-UHFFFAOYSA-N 0.000 description 1
NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 1
WYXSYVWAUAUWLD-SHUUEZRQSA-N 6-azauridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=N1 WYXSYVWAUAUWLD-SHUUEZRQSA-N 0.000 description 1
YCWQAMGASJSUIP-YFKPBYRVSA-N 6-diazo-5-oxo-L-norleucine Chemical compound OC(=O)[C@@H](N)CCC(=O)C=[N+]=[N-] YCWQAMGASJSUIP-YFKPBYRVSA-N 0.000 description 1
229960005538 6-diazo-5-oxo-L-norleucine Drugs 0.000 description 1
102100026750 60S ribosomal protein L5 Human genes 0.000 description 1
ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 1
FUXVKZWTXQUGMW-FQEVSTJZSA-N 9-Aminocamptothecin Chemical compound C1=CC(N)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 FUXVKZWTXQUGMW-FQEVSTJZSA-N 0.000 description 1
HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 description 1
102100039646 ADP-ribosylation factor-like protein 3 Human genes 0.000 description 1
101150054149 ANGPTL4 gene Proteins 0.000 description 1
102100034527 AP-1 complex subunit gamma-like 2 Human genes 0.000 description 1
102100033347 AP-2 complex subunit beta Human genes 0.000 description 1
108010088547 ARNTL Transcription Factors Proteins 0.000 description 1
102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 1
102100030089 ATP-dependent RNA helicase DHX8 Human genes 0.000 description 1
102100022117 Abnormal spindle-like microcephaly-associated protein Human genes 0.000 description 1
241000238876 Acari Species 0.000 description 1
102100036732 Actin, aortic smooth muscle Human genes 0.000 description 1
102100020963 Actin-binding LIM protein 1 Human genes 0.000 description 1
102100020961 Actin-binding LIM protein 3 Human genes 0.000 description 1
108010059616 Activins Proteins 0.000 description 1
102000005606 Activins Human genes 0.000 description 1
102100036662 Acylphosphatase-1 Human genes 0.000 description 1
102100039675 Adenylate cyclase type 2 Human genes 0.000 description 1
102100032383 Adherens junction-associated protein 1 Human genes 0.000 description 1
102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 description 1
102100031933 Adhesion G protein-coupled receptor F5 Human genes 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
102100024948 Aldehyde dehydrogenase family 16 member A1 Human genes 0.000 description 1
102100026446 Aldo-keto reductase family 1 member C1 Human genes 0.000 description 1
102100040743 Alpha-crystallin B chain Human genes 0.000 description 1
CEIZFXOZIQNICU-UHFFFAOYSA-N Alternaria alternata Crofton-weed toxin Natural products CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
102100022749 Aminopeptidase N Human genes 0.000 description 1
QGZKDVFQNNGYKY-OUBTZVSYSA-N Ammonia-15N Chemical compound [15NH3] QGZKDVFQNNGYKY-OUBTZVSYSA-N 0.000 description 1
102000052584 Anaphase-Promoting Complex-Cyclosome Apc7 Subunit Human genes 0.000 description 1
108700004602 Anaphase-Promoting Complex-Cyclosome Apc7 Subunit Proteins 0.000 description 1
108700042530 Angiopoietin-Like Protein 4 Proteins 0.000 description 1
102100025674 Angiopoietin-related protein 4 Human genes 0.000 description 1
102100036819 Ankyrin repeat and EF-hand domain-containing protein 1 Human genes 0.000 description 1
102100033900 Ankyrin repeat and SOCS box protein 13 Human genes 0.000 description 1
108090000672 Annexin A5 Proteins 0.000 description 1
102000004121 Annexin A5 Human genes 0.000 description 1
108010005853 Anti-Mullerian Hormone Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
102000014654 Aromatase Human genes 0.000 description 1
108010078554 Aromatase Proteins 0.000 description 1
102100021661 Aryl hydrocarbon receptor nuclear translocator-like protein 2 Human genes 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
101710192393 Attachment protein G3P Proteins 0.000 description 1
102100027935 Attractin-like protein 1 Human genes 0.000 description 1
NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical class C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
108091008875 B cell receptors Proteins 0.000 description 1
108700009171 B-Cell Lymphoma 3 Proteins 0.000 description 1
102100021570 B-cell lymphoma 3 protein Human genes 0.000 description 1
230000003844 B-cell-activation Effects 0.000 description 1
101700002522 BARD1 Proteins 0.000 description 1
101150050047 BHLHE40 gene Proteins 0.000 description 1
108700020463 BRCA1 Proteins 0.000 description 1
102000036365 BRCA1 Human genes 0.000 description 1
101150072950 BRCA1 gene Proteins 0.000 description 1
102100028048 BRCA1-associated RING domain protein 1 Human genes 0.000 description 1
102100023045 Band 4.1-like protein 2 Human genes 0.000 description 1
101150072667 Bcl3 gene Proteins 0.000 description 1
VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 description 1
102100026349 Beta-1,4-galactosyltransferase 1 Human genes 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
102100021277 Beta-secretase 2 Human genes 0.000 description 1
DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
229940122361 Bisphosphonate Drugs 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
MBABCNBNDNGODA-LTGLSHGVSA-N Bullatacin Natural products O=C1C(C[C@H](O)CCCCCCCCCC[C@@H](O)[C@@H]2O[C@@H]([C@@H]3O[C@H]([C@@H](O)CCCCCCCCCC)CC3)CC2)=C[C@H](C)O1 MBABCNBNDNGODA-LTGLSHGVSA-N 0.000 description 1
KGGVWMAPBXIMEM-ZRTAFWODSA-N Bullatacinone Chemical compound O1[C@@H]([C@@H](O)CCCCCCCCCC)CC[C@@H]1[C@@H]1O[C@@H]([C@H](O)CCCCCCCCCC[C@H]2OC(=O)[C@H](CC(C)=O)C2)CC1 KGGVWMAPBXIMEM-ZRTAFWODSA-N 0.000 description 1
KGGVWMAPBXIMEM-JQFCFGFHSA-N Bullatacinone Natural products O=C(C[C@H]1C(=O)O[C@H](CCCCCCCCCC[C@H](O)[C@@H]2O[C@@H]([C@@H]3O[C@@H]([C@@H](O)CCCCCCCCCC)CC3)CC2)C1)C KGGVWMAPBXIMEM-JQFCFGFHSA-N 0.000 description 1
108010037003 Buserelin Proteins 0.000 description 1
PYMDEDHDQYLBRT-DRIHCAFSSA-N Buserelin acetate Chemical compound CC(O)=O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 PYMDEDHDQYLBRT-DRIHCAFSSA-N 0.000 description 1
COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
102100022287 C-Jun-amino-terminal kinase-interacting protein 2 Human genes 0.000 description 1
108010049990 CD13 Antigens Proteins 0.000 description 1
102100032912 CD44 antigen Human genes 0.000 description 1
102100040525 CKLF-like MARVEL transmembrane domain-containing protein 5 Human genes 0.000 description 1
102100040775 CREB-regulated transcription coactivator 1 Human genes 0.000 description 1
102100040807 CUB and sushi domain-containing protein 3 Human genes 0.000 description 1
101100381481 Caenorhabditis elegans baz-2 gene Proteins 0.000 description 1
101100328884 Caenorhabditis elegans sqt-3 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102100030044 Calcium-binding protein 8 Human genes 0.000 description 1
KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 1
GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
101710169873 Capsid protein G8P Proteins 0.000 description 1
OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 1
102100033040 Carbonic anhydrase 12 Human genes 0.000 description 1
SHHKQEUPHAENFK-UHFFFAOYSA-N Carboquone Chemical compound O=C1C(C)=C(N2CC2)C(=O)C(C(COC(N)=O)OC)=C1N1CC1 SHHKQEUPHAENFK-UHFFFAOYSA-N 0.000 description 1
AOCCBINRVIKJHY-UHFFFAOYSA-N Carmofur Chemical compound CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O AOCCBINRVIKJHY-UHFFFAOYSA-N 0.000 description 1
102100035370 Cat eye syndrome critical region protein 2 Human genes 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
229940123587 Cell cycle inhibitor Drugs 0.000 description 1
102100024485 Cell division cycle-associated protein 7 Human genes 0.000 description 1
102000011682 Centromere Protein A Human genes 0.000 description 1
108010076303 Centromere Protein A Proteins 0.000 description 1
102100023344 Centromere protein F Human genes 0.000 description 1
102100023343 Centromere protein I Human genes 0.000 description 1
102100023444 Centromere protein K Human genes 0.000 description 1
102100038122 Centromere protein R Human genes 0.000 description 1
102100025832 Centromere-associated protein E Human genes 0.000 description 1
102100023309 Centrosomal protein of 152 kDa Human genes 0.000 description 1
206010008342 Cervix carcinoma Diseases 0.000 description 1
JWBOIMRXGHLCPP-UHFFFAOYSA-N Chloditan Chemical compound C=1C=CC=C(Cl)C=1C(C(Cl)Cl)C1=CC=C(Cl)C=C1 JWBOIMRXGHLCPP-UHFFFAOYSA-N 0.000 description 1
102100021809 Chorionic somatomammotropin hormone 1 Human genes 0.000 description 1
102100020736 Chromosome-associated kinesin KIF4A Human genes 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
102100026191 Class E basic helix-loop-helix protein 40 Human genes 0.000 description 1
102100034177 Clathrin coat assembly protein AP180 Human genes 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
102100021966 Coiled-coil domain-containing protein 34 Human genes 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
102100030152 Complement C1r subcomponent-like protein Human genes 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
102100032951 Condensin complex subunit 2 Human genes 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
239000004971 Cross linker Substances 0.000 description 1
229930188224 Cryptophycin Natural products 0.000 description 1
102100029141 Cyclic nucleotide-gated cation channel beta-1 Human genes 0.000 description 1
101710093674 Cyclic nucleotide-gated cation channel beta-1 Proteins 0.000 description 1
108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 1
102000009503 Cyclin-Dependent Kinase Inhibitor p18 Human genes 0.000 description 1
108010009367 Cyclin-Dependent Kinase Inhibitor p18 Proteins 0.000 description 1
102100036876 Cyclin-K Human genes 0.000 description 1
102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 1
102100032522 Cyclin-dependent kinases regulatory subunit 2 Human genes 0.000 description 1
108010072210 Cyclophilin C Proteins 0.000 description 1
102100038418 Cytoplasmic FMR1-interacting protein 2 Human genes 0.000 description 1
102100037066 Cytoplasmic dynein 2 intermediate chain 2 Human genes 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
239000012624 DNA alkylating agent Substances 0.000 description 1
102100039524 DNA endonuclease RBBP8 Human genes 0.000 description 1
102100024829 DNA polymerase delta catalytic subunit Human genes 0.000 description 1
102100036951 DNA polymerase subunit gamma-1 Human genes 0.000 description 1
102100040795 DNA primase large subunit Human genes 0.000 description 1
102100027828 DNA repair protein XRCC4 Human genes 0.000 description 1
102100027564 DNA replication complex GINS protein PSF1 Human genes 0.000 description 1
102100036218 DNA replication complex GINS protein PSF2 Human genes 0.000 description 1
102100030960 DNA replication licensing factor MCM2 Human genes 0.000 description 1
102100033720 DNA replication licensing factor MCM6 Human genes 0.000 description 1
229940124087 DNA topoisomerase II inhibitor Drugs 0.000 description 1
102100032881 DNA-binding protein SATB1 Human genes 0.000 description 1
WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
102100029790 Defensin-6 Human genes 0.000 description 1
102100024098 Deleted in lung and esophageal cancer protein 1 Human genes 0.000 description 1
102100036462 Delta-like protein 1 Human genes 0.000 description 1
XXGMIHXASFDFSM-UHFFFAOYSA-N Delta9-tetrahydrocannabinol Natural products CCCCCc1cc2OC(C)(C)C3CCC(=CC3c2c(O)c1O)C XXGMIHXASFDFSM-UHFFFAOYSA-N 0.000 description 1
NNJPGOLRFBJNIW-UHFFFAOYSA-N Demecolcine Natural products C1=C(OC)C(=O)C=C2C(NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-UHFFFAOYSA-N 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
102000007260 Deoxyribonuclease I Human genes 0.000 description 1
108010002156 Depsipeptides Proteins 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
AUGQEEXBDZWUJY-ZLJUKNTDSA-N Diacetoxyscirpenol Chemical compound C([C@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@@H]1C=C(C)CC[C@@]13COC(=O)C)O2 AUGQEEXBDZWUJY-ZLJUKNTDSA-N 0.000 description 1
AUGQEEXBDZWUJY-UHFFFAOYSA-N Diacetoxyscirpenol Natural products CC(=O)OCC12CCC(C)=CC1OC1C(O)C(OC(C)=O)C2(C)C11CO1 AUGQEEXBDZWUJY-UHFFFAOYSA-N 0.000 description 1
102100022825 Disintegrin and metalloproteinase domain-containing protein 22 Human genes 0.000 description 1
102100037980 Disks large-associated protein 5 Human genes 0.000 description 1
ZQZFYGIXNQKOAV-OCEACIFDSA-N Droloxifene Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=C(O)C=CC=1)\C1=CC=C(OCCN(C)C)C=C1 ZQZFYGIXNQKOAV-OCEACIFDSA-N 0.000 description 1
CYQFCXCEBYINGO-DLBZAZTESA-N Dronabinol Natural products C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@H]21 CYQFCXCEBYINGO-DLBZAZTESA-N 0.000 description 1
102100023275 Dual specificity mitogen-activated protein kinase kinase 3 Human genes 0.000 description 1
102100034127 Dual specificity protein phosphatase 26 Human genes 0.000 description 1
102100021179 Dynamin-3 Human genes 0.000 description 1
102100037730 Dynein regulatory complex protein 8 Human genes 0.000 description 1
229930193152 Dynemicin Natural products 0.000 description 1
102100029641 E3 ubiquitin-protein ligase DTX4 Human genes 0.000 description 1
102100029520 E3 ubiquitin-protein ligase TRIM31 Human genes 0.000 description 1
102100040067 E3 ubiquitin-protein ligase TRIM36 Human genes 0.000 description 1
102100028022 E3 ubiquitin-protein ligase TRIM47 Human genes 0.000 description 1
102100029713 E3 ubiquitin-protein ligase TRIM56 Human genes 0.000 description 1
102100028067 EGF-containing fibulin-like extracellular matrix protein 2 Human genes 0.000 description 1
101150029707 ERBB2 gene Proteins 0.000 description 1
102100031417 Elongation factor-like GTPase 1 Human genes 0.000 description 1
102100028410 Endophilin-A1 Human genes 0.000 description 1
102100038083 Endosialin Human genes 0.000 description 1
102100021860 Endothelial cell-specific molecule 1 Human genes 0.000 description 1
102100029112 Endothelin-converting enzyme 1 Human genes 0.000 description 1
AFMYMMXSQGUCBK-UHFFFAOYSA-N Endynamicin A Natural products C1#CC=CC#CC2NC(C=3C(=O)C4=C(O)C=CC(O)=C4C(=O)C=3C(O)=C3)=C3C34OC32C(C)C(C(O)=O)=C(OC)C41 AFMYMMXSQGUCBK-UHFFFAOYSA-N 0.000 description 1
102100027118 Engulfment and cell motility protein 1 Human genes 0.000 description 1
SAMRUMKYXPVKPA-VFKOLLTISA-N Enocitabine Chemical compound O=C1N=C(NC(=O)CCCCCCCCCCCCCCCCCCCCC)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 SAMRUMKYXPVKPA-VFKOLLTISA-N 0.000 description 1
102100023721 Ephrin-B2 Human genes 0.000 description 1
102100033183 Epithelial membrane protein 1 Human genes 0.000 description 1
102100033176 Epithelial membrane protein 2 Human genes 0.000 description 1
102100030146 Epithelial membrane protein 3 Human genes 0.000 description 1
OBMLHUPNRURLOK-XGRAFVIBSA-N Epitiostanol Chemical compound C1[C@@H]2S[C@@H]2C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 OBMLHUPNRURLOK-XGRAFVIBSA-N 0.000 description 1
241000283086 Equidae Species 0.000 description 1
108090000371 Esterases Proteins 0.000 description 1
102100038595 Estrogen receptor Human genes 0.000 description 1
JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
102100029775 Eukaryotic translation initiation factor 1 Human genes 0.000 description 1
102100024516 F-box only protein 5 Human genes 0.000 description 1
102100039834 F-box/LRR-repeat protein 15 Human genes 0.000 description 1
102100040936 FXYD domain-containing ion transport regulator 6 Human genes 0.000 description 1
102100034553 Fanconi anemia group J protein Human genes 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
102100031509 Fibrillin-1 Human genes 0.000 description 1
102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
102100035292 Fibroblast growth factor 14 Human genes 0.000 description 1
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
102100026149 Fibroblast growth factor receptor-like 1 Human genes 0.000 description 1
102100038546 Fibronectin type III and SPRY domain-containing protein 1 Human genes 0.000 description 1
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
102100038038 Forkhead box protein D4-like 1 Human genes 0.000 description 1
102100027269 Fructose-bisphosphate aldolase C Human genes 0.000 description 1
102100032523 G-protein coupled receptor family C group 5 member B Human genes 0.000 description 1
102000017694 GABRA3 Human genes 0.000 description 1
102000017707 GABRB3 Human genes 0.000 description 1
102100037759 GRB2-associated-binding protein 2 Human genes 0.000 description 1
229910052688 Gadolinium Inorganic materials 0.000 description 1
102100021260 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Human genes 0.000 description 1
102100035212 Gamma-aminobutyric acid type B receptor subunit 1 Human genes 0.000 description 1
102100021792 Gamma-sarcoglycan Human genes 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
102100039289 Glial fibrillary acidic protein Human genes 0.000 description 1
101710193519 Glial fibrillary acidic protein Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102100035902 Glutamate decarboxylase 1 Human genes 0.000 description 1
102100022314 Glutamate dehydrogenase 2, mitochondrial Human genes 0.000 description 1
102100030668 Glutamate receptor 4 Human genes 0.000 description 1
102100022193 Glutamate receptor ionotropic, delta-1 Human genes 0.000 description 1
102100022765 Glutamate receptor ionotropic, kainate 4 Human genes 0.000 description 1
102100033398 Glutamate-cysteine ligase regulatory subunit Human genes 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
244000060234 Gmelina philippensis Species 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
102000006771 Gonadotropins Human genes 0.000 description 1
108010086677 Gonadotropins Proteins 0.000 description 1
108010069236 Goserelin Proteins 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
102100025296 Guanine nucleotide-binding protein G(o) subunit alpha Human genes 0.000 description 1
108700039143 HMGA2 Proteins 0.000 description 1
102100031628 Heat shock 70 kDa protein 12A Human genes 0.000 description 1
102100022128 High mobility group protein B2 Human genes 0.000 description 1
102100028999 High mobility group protein HMGI-C Human genes 0.000 description 1
102100021453 Histone deacetylase 5 Human genes 0.000 description 1
102100038970 Histone-lysine N-methyltransferase EZH2 Human genes 0.000 description 1
101150073387 Hmga2 gene Proteins 0.000 description 1
208000017604 Hodgkin disease Diseases 0.000 description 1
208000010747 Hodgkins lymphoma Diseases 0.000 description 1
102100022377 Homeobox protein DLX-2 Human genes 0.000 description 1
102100029330 Homeobox protein PKNOX2 Human genes 0.000 description 1
101000761592 Homo sapiens 3 beta-hydroxysteroid dehydrogenase type 7 Proteins 0.000 description 1
101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 1
101000691083 Homo sapiens 60S ribosomal protein L5 Proteins 0.000 description 1
101000886004 Homo sapiens ADP-ribosylation factor-like protein 3 Proteins 0.000 description 1
101000924648 Homo sapiens AP-1 complex subunit gamma-like 2 Proteins 0.000 description 1
101000732341 Homo sapiens AP-2 complex subunit beta Proteins 0.000 description 1
101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 1
101000864666 Homo sapiens ATP-dependent RNA helicase DHX8 Proteins 0.000 description 1
101000900939 Homo sapiens Abnormal spindle-like microcephaly-associated protein Proteins 0.000 description 1
101000929319 Homo sapiens Actin, aortic smooth muscle Proteins 0.000 description 1
101000783802 Homo sapiens Actin-binding LIM protein 1 Proteins 0.000 description 1
101000783819 Homo sapiens Actin-binding LIM protein 3 Proteins 0.000 description 1
101000929565 Homo sapiens Acylphosphatase-1 Proteins 0.000 description 1
101000959347 Homo sapiens Adenylate cyclase type 2 Proteins 0.000 description 1
101000797959 Homo sapiens Adherens junction-associated protein 1 Proteins 0.000 description 1
101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 description 1
101000775045 Homo sapiens Adhesion G protein-coupled receptor F5 Proteins 0.000 description 1
101000761405 Homo sapiens Aldehyde dehydrogenase family 16 member A1 Proteins 0.000 description 1
101000718028 Homo sapiens Aldo-keto reductase family 1 member C1 Proteins 0.000 description 1
101000891982 Homo sapiens Alpha-crystallin B chain Proteins 0.000 description 1
101000928347 Homo sapiens Ankyrin repeat and EF-hand domain-containing protein 1 Proteins 0.000 description 1
101000925512 Homo sapiens Ankyrin repeat and SOCS box protein 13 Proteins 0.000 description 1
101000697938 Homo sapiens Attractin-like protein 1 Proteins 0.000 description 1
101001049977 Homo sapiens Band 4.1-like protein 2 Proteins 0.000 description 1
101000766145 Homo sapiens Beta-1,4-galactosyltransferase 1 Proteins 0.000 description 1
101000894883 Homo sapiens Beta-secretase 2 Proteins 0.000 description 1
101001046656 Homo sapiens C-Jun-amino-terminal kinase-interacting protein 2 Proteins 0.000 description 1
101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
101000749437 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 5 Proteins 0.000 description 1
101000891939 Homo sapiens CREB-regulated transcription coactivator 1 Proteins 0.000 description 1
101000892045 Homo sapiens CUB and sushi domain-containing protein 3 Proteins 0.000 description 1
101000794470 Homo sapiens Calcium-binding protein 8 Proteins 0.000 description 1
101000867855 Homo sapiens Carbonic anhydrase 12 Proteins 0.000 description 1
101000737671 Homo sapiens Cat eye syndrome critical region protein 2 Proteins 0.000 description 1
101000980893 Homo sapiens Cell division cycle-associated protein 7 Proteins 0.000 description 1
101000907941 Homo sapiens Centromere protein F Proteins 0.000 description 1
101000907944 Homo sapiens Centromere protein I Proteins 0.000 description 1
101000907931 Homo sapiens Centromere protein K Proteins 0.000 description 1
101000884559 Homo sapiens Centromere protein R Proteins 0.000 description 1
101000914247 Homo sapiens Centromere-associated protein E Proteins 0.000 description 1
101000908174 Homo sapiens Centrosomal protein of 152 kDa Proteins 0.000 description 1
101001139157 Homo sapiens Chromosome-associated kinesin KIF4A Proteins 0.000 description 1
101000732333 Homo sapiens Clathrin coat assembly protein AP180 Proteins 0.000 description 1
101000897100 Homo sapiens Coiled-coil domain-containing protein 34 Proteins 0.000 description 1
101000794267 Homo sapiens Complement C1r subcomponent-like protein Proteins 0.000 description 1
101000942617 Homo sapiens Condensin complex subunit 2 Proteins 0.000 description 1
101000713127 Homo sapiens Cyclin-K Proteins 0.000 description 1
101000868333 Homo sapiens Cyclin-dependent kinase 1 Proteins 0.000 description 1
101000942317 Homo sapiens Cyclin-dependent kinases regulatory subunit 2 Proteins 0.000 description 1
101000956870 Homo sapiens Cytoplasmic FMR1-interacting protein 2 Proteins 0.000 description 1
101000954718 Homo sapiens Cytoplasmic dynein 2 intermediate chain 2 Proteins 0.000 description 1
101000746134 Homo sapiens DNA endonuclease RBBP8 Proteins 0.000 description 1
101000909198 Homo sapiens DNA polymerase delta catalytic subunit Proteins 0.000 description 1
101000804964 Homo sapiens DNA polymerase subunit gamma-1 Proteins 0.000 description 1
101000611553 Homo sapiens DNA primase large subunit Proteins 0.000 description 1
101000649315 Homo sapiens DNA repair protein XRCC4 Proteins 0.000 description 1
101001080484 Homo sapiens DNA replication complex GINS protein PSF1 Proteins 0.000 description 1
101000736065 Homo sapiens DNA replication complex GINS protein PSF2 Proteins 0.000 description 1
101000583807 Homo sapiens DNA replication licensing factor MCM2 Proteins 0.000 description 1
101001018484 Homo sapiens DNA replication licensing factor MCM6 Proteins 0.000 description 1
101001018431 Homo sapiens DNA replication licensing factor MCM7 Proteins 0.000 description 1
101000655234 Homo sapiens DNA-binding protein SATB1 Proteins 0.000 description 1
101000865479 Homo sapiens Defensin-6 Proteins 0.000 description 1
101001053992 Homo sapiens Deleted in lung and esophageal cancer protein 1 Proteins 0.000 description 1
101000928537 Homo sapiens Delta-like protein 1 Proteins 0.000 description 1
101000830440 Homo sapiens Differentially expressed in FDCP 6 homolog Proteins 0.000 description 1
101000756722 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 22 Proteins 0.000 description 1
101000951365 Homo sapiens Disks large-associated protein 5 Proteins 0.000 description 1
101001115394 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 3 Proteins 0.000 description 1
101001017415 Homo sapiens Dual specificity protein phosphatase 26 Proteins 0.000 description 1
101000817599 Homo sapiens Dynamin-3 Proteins 0.000 description 1
101000966403 Homo sapiens Dynein light chain 1, cytoplasmic Proteins 0.000 description 1
101000880830 Homo sapiens Dynein regulatory complex protein 8 Proteins 0.000 description 1
101000865806 Homo sapiens E3 ubiquitin-protein ligase DTX4 Proteins 0.000 description 1
101000634974 Homo sapiens E3 ubiquitin-protein ligase TRIM31 Proteins 0.000 description 1
101000610402 Homo sapiens E3 ubiquitin-protein ligase TRIM36 Proteins 0.000 description 1
101000649007 Homo sapiens E3 ubiquitin-protein ligase TRIM47 Proteins 0.000 description 1
101000795363 Homo sapiens E3 ubiquitin-protein ligase TRIM56 Proteins 0.000 description 1
101001060248 Homo sapiens EGF-containing fibulin-like extracellular matrix protein 2 Proteins 0.000 description 1
101000921226 Homo sapiens EH domain-containing protein 2 Proteins 0.000 description 1
101000921212 Homo sapiens EH domain-containing protein 3 Proteins 0.000 description 1
101000866914 Homo sapiens Elongation factor-like GTPase 1 Proteins 0.000 description 1
101000632565 Homo sapiens Endophilin-A1 Proteins 0.000 description 1
101000884275 Homo sapiens Endosialin Proteins 0.000 description 1
101000897959 Homo sapiens Endothelial cell-specific molecule 1 Proteins 0.000 description 1
101000841259 Homo sapiens Endothelin-converting enzyme 1 Proteins 0.000 description 1
101001057862 Homo sapiens Engulfment and cell motility protein 1 Proteins 0.000 description 1
101001049392 Homo sapiens Ephrin-B2 Proteins 0.000 description 1
101000850989 Homo sapiens Epithelial membrane protein 1 Proteins 0.000 description 1
101000851002 Homo sapiens Epithelial membrane protein 2 Proteins 0.000 description 1
101001011788 Homo sapiens Epithelial membrane protein 3 Proteins 0.000 description 1
101001012787 Homo sapiens Eukaryotic translation initiation factor 1 Proteins 0.000 description 1
101001036349 Homo sapiens Eukaryotic translation initiation factor 1A, X-chromosomal Proteins 0.000 description 1
101000866302 Homo sapiens Excitatory amino acid transporter 3 Proteins 0.000 description 1
101001052797 Homo sapiens F-box only protein 5 Proteins 0.000 description 1
101000885597 Homo sapiens F-box/LRR-repeat protein 15 Proteins 0.000 description 1
101000893722 Homo sapiens FXYD domain-containing ion transport regulator 6 Proteins 0.000 description 1
101000848171 Homo sapiens Fanconi anemia group J protein Proteins 0.000 description 1
101000846893 Homo sapiens Fibrillin-1 Proteins 0.000 description 1
101000878181 Homo sapiens Fibroblast growth factor 14 Proteins 0.000 description 1
101000912518 Homo sapiens Fibroblast growth factor receptor-like 1 Proteins 0.000 description 1
101001030521 Homo sapiens Fibronectin type III and SPRY domain-containing protein 1 Proteins 0.000 description 1
101001025074 Homo sapiens Forkhead box protein D4-like 1 Proteins 0.000 description 1
101000836545 Homo sapiens Fructose-bisphosphate aldolase C Proteins 0.000 description 1
101001014684 Homo sapiens G-protein coupled receptor family C group 5 member B Proteins 0.000 description 1
101001024902 Homo sapiens GRB2-associated-binding protein 2 Proteins 0.000 description 1
101000894906 Homo sapiens Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Proteins 0.000 description 1
101000893321 Homo sapiens Gamma-aminobutyric acid receptor subunit alpha-3 Proteins 0.000 description 1
101001073597 Homo sapiens Gamma-aminobutyric acid receptor subunit beta-3 Proteins 0.000 description 1
101000926140 Homo sapiens Gem-associated protein 2 Proteins 0.000 description 1
101000873546 Homo sapiens Glutamate decarboxylase 1 Proteins 0.000 description 1
101000902361 Homo sapiens Glutamate dehydrogenase 2, mitochondrial Proteins 0.000 description 1
101001010438 Homo sapiens Glutamate receptor 4 Proteins 0.000 description 1
101000900493 Homo sapiens Glutamate receptor ionotropic, delta-1 Proteins 0.000 description 1
101000903333 Homo sapiens Glutamate receptor ionotropic, kainate 4 Proteins 0.000 description 1
101000870644 Homo sapiens Glutamate-cysteine ligase regulatory subunit Proteins 0.000 description 1
101000857837 Homo sapiens Guanine nucleotide-binding protein G(o) subunit alpha Proteins 0.000 description 1
101000866485 Homo sapiens Heat shock 70 kDa protein 12A Proteins 0.000 description 1
101001045791 Homo sapiens High mobility group protein B2 Proteins 0.000 description 1
101001016841 Homo sapiens Histamine H1 receptor Proteins 0.000 description 1
101000899255 Homo sapiens Histone deacetylase 5 Proteins 0.000 description 1
101000882127 Homo sapiens Histone-lysine N-methyltransferase EZH2 Proteins 0.000 description 1
101000901635 Homo sapiens Homeobox protein DLX-2 Proteins 0.000 description 1
101001125949 Homo sapiens Homeobox protein PKNOX2 Proteins 0.000 description 1
101001021527 Homo sapiens Huntingtin-interacting protein 1 Proteins 0.000 description 1
101001081176 Homo sapiens Hyaluronan mediated motility receptor Proteins 0.000 description 1
101001078158 Homo sapiens Integrin alpha-1 Proteins 0.000 description 1
101001078133 Homo sapiens Integrin alpha-2 Proteins 0.000 description 1
101000994378 Homo sapiens Integrin alpha-3 Proteins 0.000 description 1
101001034842 Homo sapiens Interferon-induced transmembrane protein 2 Proteins 0.000 description 1
101001034846 Homo sapiens Interferon-induced transmembrane protein 3 Proteins 0.000 description 1
101001003132 Homo sapiens Interleukin-13 receptor subunit alpha-2 Proteins 0.000 description 1
101000998176 Homo sapiens Interleukin-17D Proteins 0.000 description 1
101001010835 Homo sapiens Intraflagellar transport protein 74 homolog Proteins 0.000 description 1
101001139062 Homo sapiens Kinesin heavy chain isoform 5A Proteins 0.000 description 1
101000971638 Homo sapiens Kinesin-like protein KIF1A Proteins 0.000 description 1
101001027634 Homo sapiens Kinesin-like protein KIF21B Proteins 0.000 description 1
101001006909 Homo sapiens Kinetochore-associated protein 1 Proteins 0.000 description 1
101001046593 Homo sapiens Krueppel-like factor 16 Proteins 0.000 description 1
101001003581 Homo sapiens Lamin-B1 Proteins 0.000 description 1
101001047746 Homo sapiens Lamina-associated polypeptide 2, isoform alpha Proteins 0.000 description 1
101001047731 Homo sapiens Lamina-associated polypeptide 2, isoforms beta/gamma Proteins 0.000 description 1
101001038440 Homo sapiens Leucine zipper putative tumor suppressor 1 Proteins 0.000 description 1
101001038321 Homo sapiens Leucine-rich repeat protein 1 Proteins 0.000 description 1
101001059438 Homo sapiens Leucine-rich repeat transmembrane protein FLRT1 Proteins 0.000 description 1
101001063456 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 5 Proteins 0.000 description 1
101001004863 Homo sapiens Leucine-rich repeat-containing protein 29 Proteins 0.000 description 1
101001017833 Homo sapiens Leucine-rich repeat-containing protein 4 Proteins 0.000 description 1
101001017855 Homo sapiens Leucine-rich repeats and immunoglobulin-like domains protein 3 Proteins 0.000 description 1
101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 1
101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
101000624643 Homo sapiens M-phase inducer phosphatase 3 Proteins 0.000 description 1
101001011906 Homo sapiens Matrix metalloproteinase-14 Proteins 0.000 description 1
101001051674 Homo sapiens Meiosis-specific nuclear structural protein 1 Proteins 0.000 description 1
101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 description 1
101000969780 Homo sapiens Metallophosphoesterase 1 Proteins 0.000 description 1
101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
101000831266 Homo sapiens Metalloproteinase inhibitor 4 Proteins 0.000 description 1
101000880398 Homo sapiens Metalloreductase STEAP3 Proteins 0.000 description 1
101000628949 Homo sapiens Mitogen-activated protein kinase 10 Proteins 0.000 description 1
101000896657 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 Proteins 0.000 description 1
101000957259 Homo sapiens Mitotic spindle assembly checkpoint protein MAD2A Proteins 0.000 description 1
101001013158 Homo sapiens Myeloid leukemia factor 1 Proteins 0.000 description 1
101001013159 Homo sapiens Myeloid leukemia factor 2 Proteins 0.000 description 1
101001128456 Homo sapiens Myosin regulatory light polypeptide 9 Proteins 0.000 description 1
101001030232 Homo sapiens Myosin-9 Proteins 0.000 description 1
101000906927 Homo sapiens N-chimaerin Proteins 0.000 description 1
101000818546 Homo sapiens N-formyl peptide receptor 2 Proteins 0.000 description 1
101000651201 Homo sapiens N-sulphoglucosamine sulphohydrolase Proteins 0.000 description 1
101000837517 Homo sapiens NEDD8-activating enzyme E1 catalytic subunit Proteins 0.000 description 1
101000995164 Homo sapiens Netrin-4 Proteins 0.000 description 1
101000973218 Homo sapiens Neuralized-like protein 2 Proteins 0.000 description 1
101000927793 Homo sapiens Neuroepithelial cell-transforming gene 1 protein Proteins 0.000 description 1
101000720704 Homo sapiens Neuronal migration protein doublecortin Proteins 0.000 description 1
101000598160 Homo sapiens Nuclear mitotic apparatus protein 1 Proteins 0.000 description 1
101000974356 Homo sapiens Nuclear receptor coactivator 3 Proteins 0.000 description 1
101000633503 Homo sapiens Nuclear receptor subfamily 2 group E member 1 Proteins 0.000 description 1
101001008429 Homo sapiens Nucleobindin-2 Proteins 0.000 description 1
101000974007 Homo sapiens Nucleosome assembly protein 1-like 3 Proteins 0.000 description 1
101000586302 Homo sapiens Oncostatin-M-specific receptor subunit beta Proteins 0.000 description 1
101000721146 Homo sapiens Origin recognition complex subunit 6 Proteins 0.000 description 1
101000992396 Homo sapiens Oxysterol-binding protein-related protein 3 Proteins 0.000 description 1
101001098175 Homo sapiens P2X purinoceptor 7 Proteins 0.000 description 1
101001120082 Homo sapiens P2Y purinoceptor 13 Proteins 0.000 description 1
101000589457 Homo sapiens PCNA-interacting partner Proteins 0.000 description 1
101100136500 Homo sapiens PHACTR3 gene Proteins 0.000 description 1
101000621228 Homo sapiens POC1 centriolar protein homolog B Proteins 0.000 description 1
101000595929 Homo sapiens POLG alternative reading frame Proteins 0.000 description 1
101000782059 Homo sapiens Palmitoyltransferase ZDHHC22 Proteins 0.000 description 1
101001135199 Homo sapiens Partitioning defective 3 homolog Proteins 0.000 description 1
101001091194 Homo sapiens Peptidyl-prolyl cis-trans isomerase G Proteins 0.000 description 1
101001120097 Homo sapiens Phosphatidylinositol 3-kinase regulatory subunit beta Proteins 0.000 description 1
101000595741 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Proteins 0.000 description 1
101000595751 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Proteins 0.000 description 1
101000692672 Homo sapiens Phosphoinositide 3-kinase regulatory subunit 4 Proteins 0.000 description 1
101000929845 Homo sapiens Phospholipase ABHD3 Proteins 0.000 description 1
101001129789 Homo sapiens Piezo-type mechanosensitive ion channel component 1 Proteins 0.000 description 1
101000583189 Homo sapiens Plakophilin-4 Proteins 0.000 description 1
101000692464 Homo sapiens Platelet-derived growth factor receptor-like protein Proteins 0.000 description 1
101001126102 Homo sapiens Pleckstrin homology domain-containing family B member 1 Proteins 0.000 description 1
101000730599 Homo sapiens Pleckstrin homology domain-containing family F member 1 Proteins 0.000 description 1
101001133624 Homo sapiens Polyadenylate-binding protein-interacting protein 1 Proteins 0.000 description 1
101000997292 Homo sapiens Potassium voltage-gated channel subfamily B member 1 Proteins 0.000 description 1
101001124937 Homo sapiens Pre-mRNA-splicing factor 38B Proteins 0.000 description 1
101001039359 Homo sapiens Probable G-protein coupled receptor 158 Proteins 0.000 description 1
101001071353 Homo sapiens Probable G-protein coupled receptor 27 Proteins 0.000 description 1
101001055764 Homo sapiens Probable guanine nucleotide exchange factor MCF2L2 Proteins 0.000 description 1
101000610551 Homo sapiens Prominin-1 Proteins 0.000 description 1
101001098833 Homo sapiens Proprotein convertase subtilisin/kexin type 6 Proteins 0.000 description 1
101000875518 Homo sapiens Protein FAM110B Proteins 0.000 description 1
101000600900 Homo sapiens Protein Njmu-R1 Proteins 0.000 description 1
101000653788 Homo sapiens Protein S100-A11 Proteins 0.000 description 1
101000716750 Homo sapiens Protein SCAF11 Proteins 0.000 description 1
101000707247 Homo sapiens Protein Shroom3 Proteins 0.000 description 1
101000620365 Homo sapiens Protein TMEPAI Proteins 0.000 description 1
101000814380 Homo sapiens Protein Wnt-7b Proteins 0.000 description 1
101000863978 Homo sapiens Protein downstream neighbor of Son Proteins 0.000 description 1
101000931680 Homo sapiens Protein furry homolog Proteins 0.000 description 1
101000971468 Homo sapiens Protein kinase C zeta type Proteins 0.000 description 1
101000981737 Homo sapiens Protein lifeguard 2 Proteins 0.000 description 1
101000628776 Homo sapiens Protein mago nashi homolog Proteins 0.000 description 1
101000628758 Homo sapiens Protein mago nashi homolog 2 Proteins 0.000 description 1
101000686551 Homo sapiens Protein reprimo Proteins 0.000 description 1
101000575663 Homo sapiens Protein ripply2 Proteins 0.000 description 1
101000640056 Homo sapiens Protein strawberry notch homolog 2 Proteins 0.000 description 1
101000822478 Homo sapiens Protein transport protein Sec31B Proteins 0.000 description 1
101000760449 Homo sapiens Protein unc-93 homolog B1 Proteins 0.000 description 1
101000615238 Homo sapiens Proto-oncogene DBL Proteins 0.000 description 1
101001121371 Homo sapiens Putative transcription factor Ovo-like 1 Proteins 0.000 description 1
101001130243 Homo sapiens RAD51-associated protein 1 Proteins 0.000 description 1
101001092197 Homo sapiens RNA binding protein fox-1 homolog 3 Proteins 0.000 description 1
101000580716 Homo sapiens RNA-binding protein 24 Proteins 0.000 description 1
101001095987 Homo sapiens RalBP1-associated Eps domain-containing protein 2 Proteins 0.000 description 1
101000994788 Homo sapiens Ras GTPase-activating-like protein IQGAP3 Proteins 0.000 description 1
101000708222 Homo sapiens Ras and Rab interactor 2 Proteins 0.000 description 1
101000712972 Homo sapiens Ras association domain-containing protein 4 Proteins 0.000 description 1
101000677111 Homo sapiens Ras-like protein family member 10A Proteins 0.000 description 1
101000712576 Homo sapiens Ras-related C3 botulinum toxin substrate 3 Proteins 0.000 description 1
101001060852 Homo sapiens Ras-related protein Rab-34 Proteins 0.000 description 1
101001128094 Homo sapiens Ras-related protein Rab-34, isoform NARR Proteins 0.000 description 1
101000584765 Homo sapiens Ras-related protein Rab-6B Proteins 0.000 description 1
101001130437 Homo sapiens Ras-related protein Rap-2b Proteins 0.000 description 1
101001074548 Homo sapiens Regulating synaptic membrane exocytosis protein 2 Proteins 0.000 description 1
101000582404 Homo sapiens Replication factor C subunit 4 Proteins 0.000 description 1
101000709305 Homo sapiens Replication protein A 14 kDa subunit Proteins 0.000 description 1
101001073409 Homo sapiens Retrotransposon-derived protein PEG10 Proteins 0.000 description 1
101001091996 Homo sapiens Rho GTPase-activating protein 22 Proteins 0.000 description 1
101001106322 Homo sapiens Rho GTPase-activating protein 7 Proteins 0.000 description 1
101000666640 Homo sapiens Rho-related GTP-binding protein RhoJ Proteins 0.000 description 1
101000575639 Homo sapiens Ribonucleoside-diphosphate reductase subunit M2 Proteins 0.000 description 1
101001125547 Homo sapiens Ribose-phosphate pyrophosphokinase 2 Proteins 0.000 description 1
101000683584 Homo sapiens Ribosome-binding protein 1 Proteins 0.000 description 1
101000835992 Homo sapiens SLIT and NTRK-like protein 2 Proteins 0.000 description 1
101100366941 Homo sapiens STON1 gene Proteins 0.000 description 1
101000740178 Homo sapiens Sal-like protein 4 Proteins 0.000 description 1
101000873658 Homo sapiens Secretogranin-3 Proteins 0.000 description 1
101000685296 Homo sapiens Seizure 6-like protein Proteins 0.000 description 1
101000654734 Homo sapiens Septin-4 Proteins 0.000 description 1
101000829212 Homo sapiens Serine/arginine repetitive matrix protein 2 Proteins 0.000 description 1
101000601441 Homo sapiens Serine/threonine-protein kinase Nek2 Proteins 0.000 description 1
101000582914 Homo sapiens Serine/threonine-protein kinase PLK4 Proteins 0.000 description 1
101000836383 Homo sapiens Serpin H1 Proteins 0.000 description 1
101000703741 Homo sapiens Short stature homeobox protein 2 Proteins 0.000 description 1
101000601384 Homo sapiens Sialidase-4 Proteins 0.000 description 1
101000835995 Homo sapiens Slit homolog 1 protein Proteins 0.000 description 1
101000651893 Homo sapiens Slit homolog 3 protein Proteins 0.000 description 1
101000739172 Homo sapiens Small G protein signaling modulator 1 Proteins 0.000 description 1
101001026232 Homo sapiens Small conductance calcium-activated potassium channel protein 3 Proteins 0.000 description 1
101000684820 Homo sapiens Sodium channel protein type 3 subunit alpha Proteins 0.000 description 1
101000631937 Homo sapiens Sodium- and chloride-dependent glycine transporter 2 Proteins 0.000 description 1
101000639975 Homo sapiens Sodium-dependent noradrenaline transporter Proteins 0.000 description 1
101000685678 Homo sapiens Solute carrier family 22 member 18 Proteins 0.000 description 1
101000829127 Homo sapiens Somatostatin receptor type 2 Proteins 0.000 description 1
101000629631 Homo sapiens Sorbin and SH3 domain-containing protein 1 Proteins 0.000 description 1
101000633445 Homo sapiens Structural maintenance of chromosomes protein 2 Proteins 0.000 description 1
101000631695 Homo sapiens Succinate dehydrogenase assembly factor 3, mitochondrial Proteins 0.000 description 1
101000829168 Homo sapiens Succinate-semialdehyde dehydrogenase, mitochondrial Proteins 0.000 description 1
101000648552 Homo sapiens Sushi domain-containing protein 5 Proteins 0.000 description 1
101000801076 Homo sapiens TOM1-like protein 1 Proteins 0.000 description 1
101000651298 Homo sapiens TRAF-interacting protein with FHA domain-containing protein A Proteins 0.000 description 1
101000759312 Homo sapiens Tetratricopeptide repeat protein 12 Proteins 0.000 description 1
101000809797 Homo sapiens Thymidylate synthase Proteins 0.000 description 1
101000666234 Homo sapiens Thyroid adenoma-associated protein Proteins 0.000 description 1
101000800580 Homo sapiens Transcription factor 19 Proteins 0.000 description 1
101000904152 Homo sapiens Transcription factor E2F1 Proteins 0.000 description 1
101000866292 Homo sapiens Transcription factor E2F7 Proteins 0.000 description 1
101001028730 Homo sapiens Transcription factor JunB Proteins 0.000 description 1
101000642528 Homo sapiens Transcription factor SOX-8 Proteins 0.000 description 1
101000652736 Homo sapiens Transgelin Proteins 0.000 description 1
101000658658 Homo sapiens Transmembrane protein 106C Proteins 0.000 description 1
101000838097 Homo sapiens Transmembrane protein 121B Proteins 0.000 description 1
101000655136 Homo sapiens Transmembrane protein 14B Proteins 0.000 description 1
101000648539 Homo sapiens Transmembrane protein 59-like Proteins 0.000 description 1
101000648679 Homo sapiens Transmembrane protein 79 Proteins 0.000 description 1
101000680132 Homo sapiens Trimeric intracellular cation channel type B Proteins 0.000 description 1
101000764644 Homo sapiens Trimethyllysine dioxygenase, mitochondrial Proteins 0.000 description 1
101000597772 Homo sapiens Tropomodulin-2 Proteins 0.000 description 1
101000801701 Homo sapiens Tropomyosin alpha-1 chain Proteins 0.000 description 1
101000610609 Homo sapiens Tumor necrosis factor receptor superfamily member 10D Proteins 0.000 description 1
101000659324 Homo sapiens Twinfilin-1 Proteins 0.000 description 1
101000679525 Homo sapiens Two pore channel protein 2 Proteins 0.000 description 1
101000809490 Homo sapiens UTP-glucose-1-phosphate uridylyltransferase Proteins 0.000 description 1
101000607909 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 1 Proteins 0.000 description 1
101000753318 Homo sapiens Ubiquitin-like protein ATG12 Proteins 0.000 description 1
101000806419 Homo sapiens V-type proton ATPase subunit G 2 Proteins 0.000 description 1
101000617915 Homo sapiens VPS10 domain-containing receptor SorCS3 Proteins 0.000 description 1
101000771675 Homo sapiens WD repeat and HMG-box DNA-binding protein 1 Proteins 0.000 description 1
101000666072 Homo sapiens WD repeat-containing protein 76 Proteins 0.000 description 1
101000621390 Homo sapiens Wee1-like protein kinase Proteins 0.000 description 1
101000743863 Homo sapiens ZW10 interactor Proteins 0.000 description 1
101000916507 Homo sapiens Zinc finger CCCH-type antiviral protein 1-like Proteins 0.000 description 1
101000723827 Homo sapiens Zinc finger CCHC domain-containing protein 24 Proteins 0.000 description 1
101000723833 Homo sapiens Zinc finger E-box-binding homeobox 2 Proteins 0.000 description 1
101000788732 Homo sapiens Zinc finger protein 367 Proteins 0.000 description 1
101000915636 Homo sapiens Zinc finger protein 488 Proteins 0.000 description 1
101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 description 1
101001117143 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Proteins 0.000 description 1
101000734339 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial Proteins 0.000 description 1
101001098858 Homo sapiens cGMP-dependent 3',5'-cyclic phosphodiesterase Proteins 0.000 description 1
102100035957 Huntingtin-interacting protein 1 Human genes 0.000 description 1
102100027735 Hyaluronan mediated motility receptor Human genes 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
MPBVHIBUJCELCL-UHFFFAOYSA-N Ibandronate Chemical compound CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O MPBVHIBUJCELCL-UHFFFAOYSA-N 0.000 description 1
XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 1
XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 1
102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 1
101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
102000012745 Immunoglobulin Subunits Human genes 0.000 description 1
108010079585 Immunoglobulin Subunits Proteins 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
102100037852 Insulin-like growth factor I Human genes 0.000 description 1
102100025947 Insulin-like growth factor II Human genes 0.000 description 1
102100025323 Integrin alpha-1 Human genes 0.000 description 1
102100025305 Integrin alpha-2 Human genes 0.000 description 1
102100032819 Integrin alpha-3 Human genes 0.000 description 1
102100040020 Interferon-induced transmembrane protein 2 Human genes 0.000 description 1
102100040035 Interferon-induced transmembrane protein 3 Human genes 0.000 description 1
102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 description 1
102100033096 Interleukin-17D Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
108090000978 Interleukin-4 Proteins 0.000 description 1
108010002616 Interleukin-5 Proteins 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
108010002586 Interleukin-7 Proteins 0.000 description 1
108090001007 Interleukin-8 Proteins 0.000 description 1
108010002335 Interleukin-9 Proteins 0.000 description 1
102100029997 Intraflagellar transport protein 74 homolog Human genes 0.000 description 1
101710047833 KIAA0895 Proteins 0.000 description 1
102100020685 Kinesin heavy chain isoform 5A Human genes 0.000 description 1
102100021527 Kinesin-like protein KIF1A Human genes 0.000 description 1
102100037690 Kinesin-like protein KIF21B Human genes 0.000 description 1
102100028394 Kinetochore-associated protein 1 Human genes 0.000 description 1
102100022324 Krueppel-like factor 16 Human genes 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
JLERVPBPJHKRBJ-UHFFFAOYSA-N LY 117018 Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCC3)=CC=2)C2=CC=C(O)C=C2S1 JLERVPBPJHKRBJ-UHFFFAOYSA-N 0.000 description 1
102100026517 Lamin-B1 Human genes 0.000 description 1
102100023981 Lamina-associated polypeptide 2, isoform alpha Human genes 0.000 description 1
229920001491 Lentinan Polymers 0.000 description 1
102100040275 Leucine zipper putative tumor suppressor 1 Human genes 0.000 description 1
102100040249 Leucine-rich repeat protein 1 Human genes 0.000 description 1
102100028919 Leucine-rich repeat transmembrane protein FLRT1 Human genes 0.000 description 1
102100031036 Leucine-rich repeat-containing G-protein coupled receptor 5 Human genes 0.000 description 1
102100025967 Leucine-rich repeat-containing protein 29 Human genes 0.000 description 1
102100033304 Leucine-rich repeat-containing protein 4 Human genes 0.000 description 1
102100033284 Leucine-rich repeats and immunoglobulin-like domains protein 3 Human genes 0.000 description 1
102100035135 Limbin Human genes 0.000 description 1
108050003065 Limbin Proteins 0.000 description 1
MEPSBMMZQBMKHM-UHFFFAOYSA-N Lomatiol Natural products CC(=C/CC1=C(O)C(=O)c2ccccc2C1=O)CO MEPSBMMZQBMKHM-UHFFFAOYSA-N 0.000 description 1
102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
102100023330 M-phase inducer phosphatase 3 Human genes 0.000 description 1
101710156564 Major tail protein Gp23 Proteins 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
VJRAUFKOOPNFIQ-UHFFFAOYSA-N Marcellomycin Natural products C12=C(O)C=3C(=O)C4=C(O)C=CC(O)=C4C(=O)C=3C=C2C(C(=O)OC)C(CC)(O)CC1OC(OC1C)CC(N(C)C)C1OC(OC1C)CC(O)C1OC1CC(O)C(O)C(C)O1 VJRAUFKOOPNFIQ-UHFFFAOYSA-N 0.000 description 1
102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 1
241001441512 Maytenus serrata Species 0.000 description 1
208000000172 Medulloblastoma Diseases 0.000 description 1
102100024962 Meiosis-specific nuclear structural protein 1 Human genes 0.000 description 1
IVDYZAAPOLNZKG-KWHRADDSSA-N Mepitiostane Chemical compound O([C@@H]1[C@]2(CC[C@@H]3[C@@]4(C)C[C@H]5S[C@H]5C[C@@H]4CC[C@H]3[C@@H]2CC1)C)C1(OC)CCCC1 IVDYZAAPOLNZKG-KWHRADDSSA-N 0.000 description 1
102100023137 Metal cation symporter ZIP8 Human genes 0.000 description 1
102100021274 Metallophosphoesterase 1 Human genes 0.000 description 1
102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
102100024289 Metalloproteinase inhibitor 4 Human genes 0.000 description 1
102100037653 Metalloreductase STEAP3 Human genes 0.000 description 1
VFKZTMPDYBFSTM-KVTDHHQDSA-N Mitobronitol Chemical compound BrC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CBr VFKZTMPDYBFSTM-KVTDHHQDSA-N 0.000 description 1
102100030129 Mitochondrial 2-oxodicarboxylate carrier Human genes 0.000 description 1
102100026931 Mitogen-activated protein kinase 10 Human genes 0.000 description 1
229930192392 Mitomycin Natural products 0.000 description 1
102100021691 Mitotic checkpoint serine/threonine-protein kinase BUB1 Human genes 0.000 description 1
102100038792 Mitotic spindle assembly checkpoint protein MAD2A Human genes 0.000 description 1
102100025276 Monocarboxylate transporter 4 Human genes 0.000 description 1
108010050619 Monokines Proteins 0.000 description 1
102000013967 Monokines Human genes 0.000 description 1
102100030607 Mothers against decapentaplegic homolog 9 Human genes 0.000 description 1
101100446513 Mus musculus Fgf4 gene Proteins 0.000 description 1
241000282339 Mustela Species 0.000 description 1
102100029691 Myeloid leukemia factor 1 Human genes 0.000 description 1
102100029687 Myeloid leukemia factor 2 Human genes 0.000 description 1
102100031787 Myosin regulatory light polypeptide 9 Human genes 0.000 description 1
102100038938 Myosin-9 Human genes 0.000 description 1
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
102100023648 N-chimaerin Human genes 0.000 description 1
102100021126 N-formyl peptide receptor 2 Human genes 0.000 description 1
102100027661 N-sulphoglucosamine sulphohydrolase Human genes 0.000 description 1
102100028719 NEDD8-activating enzyme E1 catalytic subunit Human genes 0.000 description 1
206010061309 Neoplasm progression Diseases 0.000 description 1
206010029098 Neoplasm skin Diseases 0.000 description 1
108010025020 Nerve Growth Factor Proteins 0.000 description 1
102000007072 Nerve Growth Factors Human genes 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
108010088225 Nestin Proteins 0.000 description 1
102000008730 Nestin Human genes 0.000 description 1
102100022164 Neuralized-like protein 2 Human genes 0.000 description 1
102100025246 Neurogenic locus notch homolog protein 2 Human genes 0.000 description 1
108700037064 Neurogenic locus notch homolog protein 2 Proteins 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
102100025929 Neuronal migration protein doublecortin Human genes 0.000 description 1
108090000770 Neuropilin-2 Proteins 0.000 description 1
SYNHCENRCUAUNM-UHFFFAOYSA-N Nitrogen mustard N-oxide hydrochloride Chemical compound Cl.ClCC[N+]([O-])(C)CCCl SYNHCENRCUAUNM-UHFFFAOYSA-N 0.000 description 1
KGTDRFCXGRULNK-UHFFFAOYSA-N Nogalamycin Natural products COC1C(OC)(C)C(OC)C(C)OC1OC1C2=C(O)C(C(=O)C3=C(O)C=C4C5(C)OC(C(C(C5O)N(C)C)O)OC4=C3C3=O)=C3C=C2C(C(=O)OC)C(C)(O)C1 KGTDRFCXGRULNK-UHFFFAOYSA-N 0.000 description 1
102100038454 Noggin Human genes 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
102000001759 Notch1 Receptor Human genes 0.000 description 1
108010029755 Notch1 Receptor Proteins 0.000 description 1
102100023904 Nuclear autoantigenic sperm protein Human genes 0.000 description 1
101710149564 Nuclear autoantigenic sperm protein Proteins 0.000 description 1
102100036961 Nuclear mitotic apparatus protein 1 Human genes 0.000 description 1
102100022883 Nuclear receptor coactivator 3 Human genes 0.000 description 1
102100029534 Nuclear receptor subfamily 2 group E member 1 Human genes 0.000 description 1
102100027441 Nucleobindin-2 Human genes 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
102100022398 Nucleosome assembly protein 1-like 3 Human genes 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
229930187135 Olivomycin Natural products 0.000 description 1
102000043276 Oncogene Human genes 0.000 description 1
102100030098 Oncostatin-M-specific receptor subunit beta Human genes 0.000 description 1
102100026742 Opioid-binding protein/cell adhesion molecule Human genes 0.000 description 1
101710096745 Opioid-binding protein/cell adhesion molecule Proteins 0.000 description 1
102100025201 Origin recognition complex subunit 6 Human genes 0.000 description 1
101100081884 Oryza sativa subsp. japonica OSA15 gene Proteins 0.000 description 1
101000921214 Oryza sativa subsp. japonica Protein EARLY HEADING DATE 2 Proteins 0.000 description 1
102100032154 Oxysterol-binding protein-related protein 3 Human genes 0.000 description 1
102100037602 P2X purinoceptor 7 Human genes 0.000 description 1
102100026168 P2Y purinoceptor 13 Human genes 0.000 description 1
102100032341 PCNA-interacting partner Human genes 0.000 description 1
101150044441 PECAM1 gene Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102100022769 POC1 centriolar protein homolog B Human genes 0.000 description 1
101150082245 PSAG gene Proteins 0.000 description 1
102100036623 Palmitoyltransferase ZDHHC22 Human genes 0.000 description 1
VREZDOWOLGNDPW-ALTGWBOUSA-N Pancratistatin Chemical compound C1=C2[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)[C@@H]3NC(=O)C2=C(O)C2=C1OCO2 VREZDOWOLGNDPW-ALTGWBOUSA-N 0.000 description 1
VREZDOWOLGNDPW-MYVCAWNPSA-N Pancratistatin Natural products O=C1N[C@H]2[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@@H]2c2c1c(O)c1OCOc1c2 VREZDOWOLGNDPW-MYVCAWNPSA-N 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
102000003982 Parathyroid hormone Human genes 0.000 description 1
108090000445 Parathyroid hormone Proteins 0.000 description 1
102100033496 Partitioning defective 3 homolog Human genes 0.000 description 1
241001494479 Pecora Species 0.000 description 1
108010057150 Peplomycin Proteins 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
102000015731 Peptide Hormones Human genes 0.000 description 1
108010038988 Peptide Hormones Proteins 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
108010037490 Peptidyl-Prolyl Cis-Trans Isomerase NIMA-Interacting 4 Proteins 0.000 description 1
102100024968 Peptidyl-prolyl cis-trans isomerase C Human genes 0.000 description 1
102100034850 Peptidyl-prolyl cis-trans isomerase G Human genes 0.000 description 1
102100031653 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 Human genes 0.000 description 1
206010057249 Phagocytosis Diseases 0.000 description 1
102100035269 Phosphatase and actin regulator 3 Human genes 0.000 description 1
102100026177 Phosphatidylinositol 3-kinase regulatory subunit beta Human genes 0.000 description 1
102100036061 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Human genes 0.000 description 1
102100036052 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Human genes 0.000 description 1
102100026481 Phosphoinositide 3-kinase regulatory subunit 4 Human genes 0.000 description 1
102100035907 Phospholipase ABHD3 Human genes 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
102100031693 Piezo-type mechanosensitive ion channel component 1 Human genes 0.000 description 1
201000007286 Pilocytic astrocytoma Diseases 0.000 description 1
KMSKQZKKOZQFFG-HSUXVGOQSA-N Pirarubicin Chemical compound O([C@H]1[C@@H](N)C[C@@H](O[C@H]1C)O[C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1CCCCO1 KMSKQZKKOZQFFG-HSUXVGOQSA-N 0.000 description 1
108010003044 Placental Lactogen Proteins 0.000 description 1
239000000381 Placental Lactogen Substances 0.000 description 1
102100030365 Plakophilin-4 Human genes 0.000 description 1
102100026554 Platelet-derived growth factor receptor-like protein Human genes 0.000 description 1
102100037596 Platelet-derived growth factor subunit A Human genes 0.000 description 1
102100030462 Pleckstrin homology domain-containing family B member 1 Human genes 0.000 description 1
102100032592 Pleckstrin homology domain-containing family F member 1 Human genes 0.000 description 1
102100034080 Polyadenylate-binding protein-interacting protein 1 Human genes 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
102100034310 Potassium voltage-gated channel subfamily B member 1 Human genes 0.000 description 1
HFVNWDWLWUCIHC-GUPDPFMOSA-N Prednimustine Chemical compound O=C([C@@]1(O)CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)[C@@H](O)C[C@@]21C)COC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 HFVNWDWLWUCIHC-GUPDPFMOSA-N 0.000 description 1
241000288906 Primates Species 0.000 description 1
102100041031 Probable G-protein coupled receptor 158 Human genes 0.000 description 1
102100036938 Probable G-protein coupled receptor 27 Human genes 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
102100026106 Probable guanine nucleotide exchange factor MCF2L2 Human genes 0.000 description 1
108010076181 Proinsulin Proteins 0.000 description 1
102000003946 Prolactin Human genes 0.000 description 1
108010057464 Prolactin Proteins 0.000 description 1
102100040120 Prominin-1 Human genes 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
102100038946 Proprotein convertase subtilisin/kexin type 6 Human genes 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102100035978 Protein FAM110B Human genes 0.000 description 1
102100037347 Protein Njmu-R1 Human genes 0.000 description 1
102100029811 Protein S100-A11 Human genes 0.000 description 1
102100020876 Protein SCAF11 Human genes 0.000 description 1
102100031747 Protein Shroom3 Human genes 0.000 description 1
102100022429 Protein TMEPAI Human genes 0.000 description 1
102100039470 Protein Wnt-7b Human genes 0.000 description 1
102100029926 Protein downstream neighbor of Son Human genes 0.000 description 1
102100020918 Protein furry homolog Human genes 0.000 description 1
102100024924 Protein kinase C alpha type Human genes 0.000 description 1
101710109947 Protein kinase C alpha type Proteins 0.000 description 1
102100021538 Protein kinase C zeta type Human genes 0.000 description 1
102100034433 Protein kinase C-binding protein NELL2 Human genes 0.000 description 1
102100024135 Protein lifeguard 2 Human genes 0.000 description 1
102100026740 Protein mago nashi homolog Human genes 0.000 description 1
102100026743 Protein mago nashi homolog 2 Human genes 0.000 description 1
102100024763 Protein reprimo Human genes 0.000 description 1
102100025998 Protein ripply2 Human genes 0.000 description 1
102100033980 Protein strawberry notch homolog 2 Human genes 0.000 description 1
102100022485 Protein transport protein Sec31B Human genes 0.000 description 1
102100024740 Protein unc-93 homolog B1 Human genes 0.000 description 1
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
102100021384 Proto-oncogene DBL Human genes 0.000 description 1
241000737257 Pteris <genus> Species 0.000 description 1
102100026326 Putative transcription factor Ovo-like 1 Human genes 0.000 description 1
102100031535 RAD51-associated protein 1 Human genes 0.000 description 1
102100035530 RNA binding protein fox-1 homolog 3 Human genes 0.000 description 1
102100027487 RNA-binding protein 24 Human genes 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
102000004914 RYR3 Human genes 0.000 description 1
108060007242 RYR3 Proteins 0.000 description 1
102100021313 Rab11 family-interacting protein 4 Human genes 0.000 description 1
102000002490 Rad51 Recombinase Human genes 0.000 description 1
108010068097 Rad51 Recombinase Proteins 0.000 description 1
102100037884 RalBP1-associated Eps domain-containing protein 2 Human genes 0.000 description 1
102100034417 Ras GTPase-activating-like protein IQGAP3 Human genes 0.000 description 1
102100031490 Ras and Rab interactor 2 Human genes 0.000 description 1
102100021577 Ras-like protein family member 10A Human genes 0.000 description 1
102100031921 Ras-related protein Rab-34, isoform NARR Human genes 0.000 description 1
102100030014 Ras-related protein Rab-6B Human genes 0.000 description 1
102100031421 Ras-related protein Rap-2b Human genes 0.000 description 1
101100372762 Rattus norvegicus Flt1 gene Proteins 0.000 description 1
101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 description 1
101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 description 1
102100036266 Regulating synaptic membrane exocytosis protein 2 Human genes 0.000 description 1
102100030814 Regulator of G-protein signaling 9 Human genes 0.000 description 1
108090000103 Relaxin Proteins 0.000 description 1
102000003743 Relaxin Human genes 0.000 description 1
102100030542 Replication factor C subunit 4 Human genes 0.000 description 1
102100034372 Replication protein A 14 kDa subunit Human genes 0.000 description 1
102100035844 Retrotransposon-derived protein PEG10 Human genes 0.000 description 1
OWPCHSCAPHNHAV-UHFFFAOYSA-N Rhizoxin Natural products C1C(O)C2(C)OC2C=CC(C)C(OC(=O)C2)CC2CC2OC2C(=O)OC1C(C)C(OC)C(C)=CC=CC(C)=CC1=COC(C)=N1 OWPCHSCAPHNHAV-UHFFFAOYSA-N 0.000 description 1
102100038337 Rho-related GTP-binding protein RhoJ Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
102100026006 Ribonucleoside-diphosphate reductase subunit M2 Human genes 0.000 description 1
102100029509 Ribose-phosphate pyrophosphokinase 2 Human genes 0.000 description 1
102100023542 Ribosome-binding protein 1 Human genes 0.000 description 1
IIDJRNMFWXDHID-UHFFFAOYSA-N Risedronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CC1=CC=CN=C1 IIDJRNMFWXDHID-UHFFFAOYSA-N 0.000 description 1
NSFWWJIQIKBZMJ-YKNYLIOZSA-N Roridin A Chemical compound C([C@]12[C@]3(C)[C@H]4C[C@H]1O[C@@H]1C=C(C)CC[C@@]13COC(=O)[C@@H](O)[C@H](C)CCO[C@H](\C=C\C=C/C(=O)O4)[C@H](O)C)O2 NSFWWJIQIKBZMJ-YKNYLIOZSA-N 0.000 description 1
CIEYTVIYYGTCCI-UHFFFAOYSA-N SJ000286565 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(O)C(=O)C2=C1 CIEYTVIYYGTCCI-UHFFFAOYSA-N 0.000 description 1
108091006627 SLC12A9 Proteins 0.000 description 1
108091006601 SLC16A3 Proteins 0.000 description 1
108091006775 SLC18A2 Proteins 0.000 description 1
102000012979 SLC1A1 Human genes 0.000 description 1
108091006427 SLC25A21 Proteins 0.000 description 1
108091006939 SLC39A8 Proteins 0.000 description 1
102100025500 SLIT and NTRK-like protein 2 Human genes 0.000 description 1
102100037192 Sal-like protein 4 Human genes 0.000 description 1
108010084592 Saporins Proteins 0.000 description 1
102100035897 Secretogranin-3 Human genes 0.000 description 1
102100023160 Seizure 6-like protein Human genes 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
102100032743 Septin-4 Human genes 0.000 description 1
102100023657 Serine/arginine repetitive matrix protein 2 Human genes 0.000 description 1
102100037703 Serine/threonine-protein kinase Nek2 Human genes 0.000 description 1
102100030267 Serine/threonine-protein kinase PLK4 Human genes 0.000 description 1
102100027287 Serpin H1 Human genes 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
102100031976 Short stature homeobox protein 2 Human genes 0.000 description 1
102100037729 Sialidase-4 Human genes 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
229920000519 Sizofiran Polymers 0.000 description 1
208000000453 Skin Neoplasms Diseases 0.000 description 1
102100025490 Slit homolog 1 protein Human genes 0.000 description 1
108700031283 Smad8 Proteins 0.000 description 1
101150064968 Smad9 gene Proteins 0.000 description 1
102100037270 Small G protein signaling modulator 1 Human genes 0.000 description 1
102100037442 Small conductance calcium-activated potassium channel protein 3 Human genes 0.000 description 1
102100034803 Small nuclear ribonucleoprotein-associated protein N Human genes 0.000 description 1
102100023720 Sodium channel protein type 3 subunit alpha Human genes 0.000 description 1
102100028886 Sodium- and chloride-dependent glycine transporter 2 Human genes 0.000 description 1
102100036742 Solute carrier family 12 member 9 Human genes 0.000 description 1
102100023102 Solute carrier family 22 member 18 Human genes 0.000 description 1
102100029329 Somatostatin receptor type 1 Human genes 0.000 description 1
102100023802 Somatostatin receptor type 2 Human genes 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
102100026834 Sorbin and SH3 domain-containing protein 1 Human genes 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
102100021683 Stonin-1 Human genes 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
102100029540 Structural maintenance of chromosomes protein 2 Human genes 0.000 description 1
102100028996 Succinate dehydrogenase assembly factor 3, mitochondrial Human genes 0.000 description 1
102100023673 Succinate-semialdehyde dehydrogenase, mitochondrial Human genes 0.000 description 1
241000282887 Suidae Species 0.000 description 1
102100028859 Sushi domain-containing protein 5 Human genes 0.000 description 1
102100034333 Synaptic vesicular amine transporter Human genes 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
BXFOFFBJRFZBQZ-QYWOHJEZSA-N T-2 toxin Chemical compound C([C@@]12[C@]3(C)[C@H](OC(C)=O)[C@@H](O)[C@H]1O[C@H]1[C@]3(COC(C)=O)C[C@@H](C(=C1)C)OC(=O)CC(C)C)O2 BXFOFFBJRFZBQZ-QYWOHJEZSA-N 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
206010042971 T-cell lymphoma Diseases 0.000 description 1
208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
102100033693 TOM1-like protein 1 Human genes 0.000 description 1
102100027651 TRAF-interacting protein with FHA domain-containing protein A Human genes 0.000 description 1
108010017842 Telomerase Proteins 0.000 description 1
CGMTUJFWROPELF-UHFFFAOYSA-N Tenuazonic acid Natural products CCC(C)C1NC(=O)C(=C(C)/O)C1=O CGMTUJFWROPELF-UHFFFAOYSA-N 0.000 description 1
102100023284 Tetratricopeptide repeat protein 12 Human genes 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
102100038618 Thymidylate synthase Human genes 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102100033504 Thyroglobulin Human genes 0.000 description 1
102100038148 Thyroid adenoma-associated protein Human genes 0.000 description 1
239000000317 Topoisomerase II Inhibitor Substances 0.000 description 1
102100033159 Transcription factor 19 Human genes 0.000 description 1
102100024026 Transcription factor E2F1 Human genes 0.000 description 1
102100031556 Transcription factor E2F7 Human genes 0.000 description 1
102100037168 Transcription factor JunB Human genes 0.000 description 1
102100036731 Transcription factor SOX-8 Human genes 0.000 description 1
101710169732 Transforming growth factor beta activator LRRC32 Proteins 0.000 description 1
102100031013 Transgelin Human genes 0.000 description 1
108700019146 Transgenes Proteins 0.000 description 1
102100034851 Transmembrane protein 106C Human genes 0.000 description 1
102100028600 Transmembrane protein 121B Human genes 0.000 description 1
102100033027 Transmembrane protein 14B Human genes 0.000 description 1
102100028863 Transmembrane protein 59-like Human genes 0.000 description 1
102100028839 Transmembrane protein 79 Human genes 0.000 description 1
UMILHIMHKXVDGH-UHFFFAOYSA-N Triethylene glycol diglycidyl ether Chemical compound C1OC1COCCOCCOCCOCC1CO1 UMILHIMHKXVDGH-UHFFFAOYSA-N 0.000 description 1
102100022234 Trimeric intracellular cation channel type B Human genes 0.000 description 1
102100026223 Trimethyllysine dioxygenase, mitochondrial Human genes 0.000 description 1
102100035293 Tropomodulin-2 Human genes 0.000 description 1
102100033632 Tropomyosin alpha-1 chain Human genes 0.000 description 1
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
229940122618 Trypsin inhibitor Drugs 0.000 description 1
101710162629 Trypsin inhibitor Proteins 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
102100040247 Tumor necrosis factor Human genes 0.000 description 1
102100040110 Tumor necrosis factor receptor superfamily member 10D Human genes 0.000 description 1
206010054094 Tumour necrosis Diseases 0.000 description 1
102100036223 Twinfilin-1 Human genes 0.000 description 1
102100022609 Two pore channel protein 2 Human genes 0.000 description 1
102100038834 UTP-glucose-1-phosphate uridylyltransferase Human genes 0.000 description 1
102100039865 Ubiquitin carboxyl-terminal hydrolase 1 Human genes 0.000 description 1
102100022016 Ubiquitin-like protein ATG12 Human genes 0.000 description 1
102100025704 Uncharacterized protein KIAA0895 Human genes 0.000 description 1
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
101150117115 V gene Proteins 0.000 description 1
102100037430 V-type proton ATPase subunit G 2 Human genes 0.000 description 1
108091008605 VEGF receptors Proteins 0.000 description 1
102100021946 VPS10 domain-containing receptor SorCS3 Human genes 0.000 description 1
108010073925 Vascular Endothelial Growth Factor B Proteins 0.000 description 1
108010073923 Vascular Endothelial Growth Factor C Proteins 0.000 description 1
102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 1
102100038217 Vascular endothelial growth factor B Human genes 0.000 description 1
102100038232 Vascular endothelial growth factor C Human genes 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
102100035071 Vimentin Human genes 0.000 description 1
108010065472 Vimentin Proteins 0.000 description 1
241000863480 Vinca Species 0.000 description 1
229940122803 Vinca alkaloid Drugs 0.000 description 1
241000700605 Viruses Species 0.000 description 1
102100029469 WD repeat and HMG-box DNA-binding protein 1 Human genes 0.000 description 1
102100038092 WD repeat-containing protein 76 Human genes 0.000 description 1
102100023037 Wee1-like protein kinase Human genes 0.000 description 1
102100024780 YEATS domain-containing protein 4 Human genes 0.000 description 1
101710107170 YEATS domain-containing protein 4 Proteins 0.000 description 1
102100039102 ZW10 interactor Human genes 0.000 description 1
102100028877 Zinc finger CCCH-type antiviral protein 1-like Human genes 0.000 description 1
102100028460 Zinc finger CCHC domain-containing protein 24 Human genes 0.000 description 1
102100025438 Zinc finger protein 367 Human genes 0.000 description 1
102100029033 Zinc finger protein 488 Human genes 0.000 description 1
SPJCRMJCFSJKDE-ZWBUGVOYSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)C(=O)CC1=CC=C(N(CCCl)CCCl)C=C1 SPJCRMJCFSJKDE-ZWBUGVOYSA-N 0.000 description 1
ZPCCSZFPOXBNDL-ZSTSFXQOSA-N [(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoe Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]([C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)OC(C)=O)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 ZPCCSZFPOXBNDL-ZSTSFXQOSA-N 0.000 description 1
IFJUINDAXYAPTO-UUBSBJJBSA-N [(8r,9s,13s,14s,17s)-17-[2-[4-[4-[bis(2-chloroethyl)amino]phenyl]butanoyloxy]acetyl]oxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] benzoate Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4OC(=O)COC(=O)CCCC=1C=CC(=CC=1)N(CCCl)CCCl)C)CC2=CC=3OC(=O)C1=CC=CC=C1 IFJUINDAXYAPTO-UUBSBJJBSA-N 0.000 description 1
IHGLINDYFMDHJG-UHFFFAOYSA-N [2-(4-methoxyphenyl)-3,4-dihydronaphthalen-1-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanone Chemical compound C1=CC(OC)=CC=C1C(CCC1=CC=CC=C11)=C1C(=O)C(C=C1)=CC=C1OCCN1CCCC1 IHGLINDYFMDHJG-UHFFFAOYSA-N 0.000 description 1
XZSRRNFBEIOBDA-CFNBKWCHSA-N [2-[(2s,4s)-4-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1h-tetracen-2-yl]-2-oxoethyl] 2,2-diethoxyacetate Chemical compound O([C@H]1C[C@](CC2=C(O)C=3C(=O)C4=CC=CC(OC)=C4C(=O)C=3C(O)=C21)(O)C(=O)COC(=O)C(OCC)OCC)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 XZSRRNFBEIOBDA-CFNBKWCHSA-N 0.000 description 1
102100024148 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Human genes 0.000 description 1
102100024150 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial Human genes 0.000 description 1
102100034825 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial Human genes 0.000 description 1
229960002184 abarelix Drugs 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
ZOZKYEHVNDEUCO-XUTVFYLZSA-N aceglatone Chemical compound O1C(=O)[C@H](OC(C)=O)[C@@H]2OC(=O)[C@@H](OC(=O)C)[C@@H]21 ZOZKYEHVNDEUCO-XUTVFYLZSA-N 0.000 description 1
229950002684 aceglatone Drugs 0.000 description 1
229930183665 actinomycin Natural products 0.000 description 1
239000000488 activin Substances 0.000 description 1
229940037127 actonel Drugs 0.000 description 1
229950004955 adozelesin Drugs 0.000 description 1
BYRVKDUQDLJUBX-JJCDCTGGSA-N adozelesin Chemical compound C1=CC=C2OC(C(=O)NC=3C=C4C=C(NC4=CC=3)C(=O)N3C[C@H]4C[C@]44C5=C(C(C=C43)=O)NC=C5C)=CC2=C1 BYRVKDUQDLJUBX-JJCDCTGGSA-N 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
229940009456 adriamycin Drugs 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
230000004931 aggregating effect Effects 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
229940062527 alendronate Drugs 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
150000008052 alkyl sulfonates Chemical class 0.000 description 1
229940100198 alkylating agent Drugs 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
229960000473 altretamine Drugs 0.000 description 1
229940037003 alum Drugs 0.000 description 1
229960002749 aminolevulinic acid Drugs 0.000 description 1
XCPGHVQEEXUHNC-UHFFFAOYSA-N amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 description 1
229960001220 amsacrine Drugs 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
101150085085 anapc7 gene Proteins 0.000 description 1
229960002932 anastrozole Drugs 0.000 description 1
BBDAGFIXKZCXAH-CCXZUQQUSA-N ancitabine Chemical compound N=C1C=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3OC2=N1 BBDAGFIXKZCXAH-CCXZUQQUSA-N 0.000 description 1
229950000242 ancitabine Drugs 0.000 description 1
239000003098 androgen Substances 0.000 description 1
229940030486 androgens Drugs 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000002280 anti-androgenic effect Effects 0.000 description 1
230000001772 anti-angiogenic effect Effects 0.000 description 1
229940046836 anti-estrogen Drugs 0.000 description 1
230000001833 anti-estrogenic effect Effects 0.000 description 1
230000003432 anti-folate effect Effects 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
239000000868 anti-mullerian hormone Substances 0.000 description 1
239000000051 antiandrogen Substances 0.000 description 1
229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
238000011091 antibody purification Methods 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
229940127074 antifolate Drugs 0.000 description 1
239000013059 antihormonal agent Substances 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
229940045687 antimetabolites folic acid analogs Drugs 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
230000001640 apoptogenic effect Effects 0.000 description 1
238000003782 apoptosis assay Methods 0.000 description 1
150000008209 arabinosides Chemical class 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000009697 arginine Nutrition 0.000 description 1
229940078010 arimidex Drugs 0.000 description 1
229940087620 aromasin Drugs 0.000 description 1
239000003886 aromatase inhibitor Substances 0.000 description 1
229940046844 aromatase inhibitors Drugs 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
108010044540 auristatin Proteins 0.000 description 1
229960002756 azacitidine Drugs 0.000 description 1
229950011321 azaserine Drugs 0.000 description 1
150000001541 aziridines Chemical class 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
229960000397 bevacizumab Drugs 0.000 description 1
229960000997 bicalutamide Drugs 0.000 description 1
238000002306 biochemical method Methods 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
238000005460 biophysical method Methods 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
229950008548 bisantrene Drugs 0.000 description 1
150000004663 bisphosphonates Chemical class 0.000 description 1
229950006844 bizelesin Drugs 0.000 description 1
230000037396 body weight Effects 0.000 description 1
238000006664 bond formation reaction Methods 0.000 description 1
108010006025 bovine growth hormone Proteins 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
229960005520 bryostatin Drugs 0.000 description 1
MJQUEDHRCUIRLF-TVIXENOKSA-N bryostatin 1 Chemical compound C([C@@H]1CC(/[C@@H]([C@@](C(C)(C)/C=C/2)(O)O1)OC(=O)/C=C/C=C/CCC)=C\C(=O)OC)[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H](O1)C[C@H](OC(C)=O)C(C)(C)[C@]1(O)C[C@@H]1C\C(=C\C(=O)OC)C[C@H]\2O1 MJQUEDHRCUIRLF-TVIXENOKSA-N 0.000 description 1
MUIWQCKLQMOUAT-AKUNNTHJSA-N bryostatin 20 Natural products COC(=O)C=C1C[C@@]2(C)C[C@]3(O)O[C@](C)(C[C@@H](O)CC(=O)O[C@](C)(C[C@@]4(C)O[C@](O)(CC5=CC(=O)O[C@]45C)C(C)(C)C=C[C@@](C)(C1)O2)[C@@H](C)O)C[C@H](OC(=O)C(C)(C)C)C3(C)C MUIWQCKLQMOUAT-AKUNNTHJSA-N 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
244000309464 bull Species 0.000 description 1
MBABCNBNDNGODA-LUVUIASKSA-N bullatacin Chemical compound O1[C@@H]([C@@H](O)CCCCCCCCCC)CC[C@@H]1[C@@H]1O[C@@H]([C@H](O)CCCCCCCCCC[C@@H](O)CC=2C(O[C@@H](C)C=2)=O)CC1 MBABCNBNDNGODA-LUVUIASKSA-N 0.000 description 1
229960005064 buserelin acetate Drugs 0.000 description 1
229960002092 busulfan Drugs 0.000 description 1
102100039125 cAMP-regulated phosphoprotein 21 Human genes 0.000 description 1
102100038953 cGMP-dependent 3',5'-cyclic phosphodiesterase Human genes 0.000 description 1
108700002839 cactinomycin Proteins 0.000 description 1
229950009908 cactinomycin Drugs 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229950009823 calusterone Drugs 0.000 description 1
IVFYLRMMHVYGJH-PVPPCFLZSA-N calusterone Chemical compound C1C[C@]2(C)[C@](O)(C)CC[C@H]2[C@@H]2[C@@H](C)CC3=CC(=O)CC[C@]3(C)[C@H]21 IVFYLRMMHVYGJH-PVPPCFLZSA-N 0.000 description 1
229940088954 camptosar Drugs 0.000 description 1
VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
229940127093 camptothecin Drugs 0.000 description 1
230000005907 cancer growth Effects 0.000 description 1
229960004117 capecitabine Drugs 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229960002115 carboquone Drugs 0.000 description 1
XREUEWVEMYWFFA-CSKJXFQVSA-N carminomycin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=C(O)C=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XREUEWVEMYWFFA-CSKJXFQVSA-N 0.000 description 1
229930188550 carminomycin Natural products 0.000 description 1
XREUEWVEMYWFFA-UHFFFAOYSA-N carminomycin I Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=C(O)C=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XREUEWVEMYWFFA-UHFFFAOYSA-N 0.000 description 1
229960003261 carmofur Drugs 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
229950001725 carubicin Drugs 0.000 description 1
BBZDXMBRAFTCAA-AREMUKBSSA-N carzelesin Chemical compound C1=2NC=C(C)C=2C([C@H](CCl)CN2C(=O)C=3NC4=CC=C(C=C4C=3)NC(=O)C3=CC4=CC=C(C=C4O3)N(CC)CC)=C2C=C1OC(=O)NC1=CC=CC=C1 BBZDXMBRAFTCAA-AREMUKBSSA-N 0.000 description 1
229950007509 carzelesin Drugs 0.000 description 1
108010047060 carzinophilin Proteins 0.000 description 1
230000006369 cell cycle progression Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000022534 cell killing Effects 0.000 description 1
239000002771 cell marker Substances 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000036978 cell physiology Effects 0.000 description 1
230000002032 cellular defenses Effects 0.000 description 1
230000004700 cellular uptake Effects 0.000 description 1
210000001638 cerebellum Anatomy 0.000 description 1
201000010881 cervical cancer Diseases 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
230000000973 chemotherapeutic effect Effects 0.000 description 1
229960004630 chlorambucil Drugs 0.000 description 1
JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
229960001480 chlorozotocin Drugs 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
230000010428 chromatin condensation Effects 0.000 description 1
ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 description 1
229960002286 clodronic acid Drugs 0.000 description 1
230000004186 co-expression Effects 0.000 description 1
238000006258 combinatorial reaction Methods 0.000 description 1
230000001447 compensatory effect Effects 0.000 description 1
230000004154 complement system Effects 0.000 description 1
239000008139 complexing agent Substances 0.000 description 1
238000002591 computed tomography Methods 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000005289 controlled pore glass Substances 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
230000005574 cross-species transmission Effects 0.000 description 1
PSNOPSMXOBPNNV-VVCTWANISA-N cryptophycin 1 Chemical compound C1=C(Cl)C(OC)=CC=C1C[C@@H]1C(=O)NC[C@@H](C)C(=O)O[C@@H](CC(C)C)C(=O)O[C@H]([C@H](C)[C@@H]2[C@H](O2)C=2C=CC=CC=2)C/C=C/C(=O)N1 PSNOPSMXOBPNNV-VVCTWANISA-N 0.000 description 1
108010089438 cryptophycin 1 Proteins 0.000 description 1
108010090203 cryptophycin 8 Proteins 0.000 description 1
PSNOPSMXOBPNNV-UHFFFAOYSA-N cryptophycin-327 Natural products C1=C(Cl)C(OC)=CC=C1CC1C(=O)NCC(C)C(=O)OC(CC(C)C)C(=O)OC(C(C)C2C(O2)C=2C=CC=CC=2)CC=CC(=O)N1 PSNOPSMXOBPNNV-UHFFFAOYSA-N 0.000 description 1
108010083633 cyclic AMP-regulated phosphoprotein ARPP-21 Proteins 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
239000002619 cytotoxin Substances 0.000 description 1
DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
229960005052 demecolcine Drugs 0.000 description 1
229950003913 detorubicin Drugs 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
WVYXNIXAMZOZFK-UHFFFAOYSA-N diaziquone Chemical compound O=C1C(NC(=O)OCC)=C(N2CC2)C(=O)C(NC(=O)OCC)=C1N1CC1 WVYXNIXAMZOZFK-UHFFFAOYSA-N 0.000 description 1
229950002389 diaziquone Drugs 0.000 description 1
230000007120 differential activation Effects 0.000 description 1
PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
238000009826 distribution Methods 0.000 description 1
125000002228 disulfide group Chemical group 0.000 description 1
150000002019 disulfides Chemical class 0.000 description 1
VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
239000003534 dna topoisomerase inhibitor Substances 0.000 description 1
AMRJKAQTDDKMCE-UHFFFAOYSA-N dolastatin Chemical compound CC(C)C(N(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(C(C)C)C(OC)CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(C=1SC=CN=1)CC1=CC=CC=C1 AMRJKAQTDDKMCE-UHFFFAOYSA-N 0.000 description 1
229930188854 dolastatin Natural products 0.000 description 1
ZWAOHEXOSAUJHY-ZIYNGMLESA-N doxifluridine Chemical compound O[C@@H]1[C@H](O)[C@@H](C)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ZWAOHEXOSAUJHY-ZIYNGMLESA-N 0.000 description 1
229950005454 doxifluridine Drugs 0.000 description 1
229950004203 droloxifene Drugs 0.000 description 1
NOTIQUSPUUHHEH-UXOVVSIBSA-N dromostanolone propionate Chemical compound C([C@@H]1CC2)C(=O)[C@H](C)C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](OC(=O)CC)[C@@]2(C)CC1 NOTIQUSPUUHHEH-UXOVVSIBSA-N 0.000 description 1
229960004242 dronabinol Drugs 0.000 description 1
229950004683 drostanolone propionate Drugs 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
229960005501 duocarmycin Drugs 0.000 description 1
VQNATVDKACXKTF-XELLLNAOSA-N duocarmycin Chemical compound COC1=C(OC)C(OC)=C2NC(C(=O)N3C4=CC(=O)C5=C([C@@]64C[C@@H]6C3)C=C(N5)C(=O)OC)=CC2=C1 VQNATVDKACXKTF-XELLLNAOSA-N 0.000 description 1
229930184221 duocarmycin Natural products 0.000 description 1
AFMYMMXSQGUCBK-AKMKHHNQSA-N dynemicin a Chemical compound C1#C\C=C/C#C[C@@H]2NC(C=3C(=O)C4=C(O)C=CC(O)=C4C(=O)C=3C(O)=C3)=C3[C@@]34O[C@]32[C@@H](C)C(C(O)=O)=C(OC)[C@H]41 AFMYMMXSQGUCBK-AKMKHHNQSA-N 0.000 description 1
FSIRXIHZBIXHKT-MHTVFEQDSA-N edatrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CC(CC)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FSIRXIHZBIXHKT-MHTVFEQDSA-N 0.000 description 1
229950006700 edatrexate Drugs 0.000 description 1
XOPYFXBZMVTEJF-PDACKIITSA-N eleutherobin Chemical compound C(/[C@H]1[C@H](C(=CC[C@@H]1C(C)C)C)C[C@@H]([C@@]1(C)O[C@@]2(C=C1)OC)OC(=O)\C=C\C=1N=CN(C)C=1)=C2\CO[C@@H]1OC[C@@H](O)[C@@H](O)[C@@H]1OC(C)=O XOPYFXBZMVTEJF-PDACKIITSA-N 0.000 description 1
XOPYFXBZMVTEJF-UHFFFAOYSA-N eleutherobin Natural products C1=CC2(OC)OC1(C)C(OC(=O)C=CC=1N=CN(C)C=1)CC(C(=CCC1C(C)C)C)C1C=C2COC1OCC(O)C(O)C1OC(C)=O XOPYFXBZMVTEJF-UHFFFAOYSA-N 0.000 description 1
229950000549 elliptinium acetate Drugs 0.000 description 1
231100001129 embryonic lethality Toxicity 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
230000003511 endothelial effect Effects 0.000 description 1
JOZGNYDSEBIJDH-UHFFFAOYSA-N eniluracil Chemical compound O=C1NC=C(C#C)C(=O)N1 JOZGNYDSEBIJDH-UHFFFAOYSA-N 0.000 description 1
229950010213 eniluracil Drugs 0.000 description 1
229950011487 enocitabine Drugs 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
230000001973 epigenetic effect Effects 0.000 description 1
YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 1
229950002973 epitiostanol Drugs 0.000 description 1
229930013356 epothilone Natural products 0.000 description 1
150000003883 epothilone derivatives Chemical class 0.000 description 1
229960001433 erlotinib Drugs 0.000 description 1
ITSGNOIFAJAQHJ-BMFNZSJVSA-N esorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)C[C@H](C)O1 ITSGNOIFAJAQHJ-BMFNZSJVSA-N 0.000 description 1
229950002017 esorubicin Drugs 0.000 description 1
LJQQFQHBKUKHIS-WJHRIEJJSA-N esperamicin Chemical compound O1CC(NC(C)C)C(OC)CC1OC1C(O)C(NOC2OC(C)C(SC)C(O)C2)C(C)OC1OC1C(\C2=C/CSSSC)=C(NC(=O)OC)C(=O)C(OC3OC(C)C(O)C(OC(=O)C=4C(=CC(OC)=C(OC)C=4)NC(=O)C(=C)OC)C3)C2(O)C#C\C=C/C#C1 LJQQFQHBKUKHIS-WJHRIEJJSA-N 0.000 description 1
229960001842 estramustine Drugs 0.000 description 1
FRPJXPJMRWBBIH-RBRWEJTLSA-N estramustine Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 FRPJXPJMRWBBIH-RBRWEJTLSA-N 0.000 description 1
229940011871 estrogen Drugs 0.000 description 1
239000000262 estrogen Substances 0.000 description 1
239000000328 estrogen antagonist Substances 0.000 description 1
108010038795 estrogen receptors Proteins 0.000 description 1
QSRLNKCNOLVZIR-KRWDZBQOSA-N ethyl (2s)-2-[[2-[4-[bis(2-chloroethyl)amino]phenyl]acetyl]amino]-4-methylsulfanylbutanoate Chemical compound CCOC(=O)[C@H](CCSC)NC(=O)CC1=CC=C(N(CCCl)CCCl)C=C1 QSRLNKCNOLVZIR-KRWDZBQOSA-N 0.000 description 1
HVCNNTAUBZIYCG-UHFFFAOYSA-N ethyl 2-[4-[(6-chloro-1,3-benzothiazol-2-yl)oxy]phenoxy]propanoate Chemical compound C1=CC(OC(C)C(=O)OCC)=CC=C1OC1=NC2=CC=C(Cl)C=C2S1 HVCNNTAUBZIYCG-UHFFFAOYSA-N 0.000 description 1
229940009626 etidronate Drugs 0.000 description 1
229960005237 etoglucid Drugs 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
229940085363 evista Drugs 0.000 description 1
229960000255 exemestane Drugs 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
229950011548 fadrozole Drugs 0.000 description 1
229940043168 fareston Drugs 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
229940087476 femara Drugs 0.000 description 1
201000001169 fibrillary astrocytoma Diseases 0.000 description 1
229940126864 fibroblast growth factor Drugs 0.000 description 1
108090000047 fibroblast growth factor 13 Proteins 0.000 description 1
102000003684 fibroblast growth factor 13 Human genes 0.000 description 1
235000019688 fish Nutrition 0.000 description 1
ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 description 1
229960000961 floxuridine Drugs 0.000 description 1
229960000390 fludarabine Drugs 0.000 description 1
GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 1
239000012530 fluid Substances 0.000 description 1
229960002074 flutamide Drugs 0.000 description 1
MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
229960000304 folic acid Drugs 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
239000004052 folic acid antagonist Substances 0.000 description 1
150000002224 folic acids Chemical class 0.000 description 1
238000009472 formulation Methods 0.000 description 1
229940001490 fosamax Drugs 0.000 description 1
YAKWPXVTIGTRJH-UHFFFAOYSA-N fotemustine Chemical compound CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O YAKWPXVTIGTRJH-UHFFFAOYSA-N 0.000 description 1
229960004783 fotemustine Drugs 0.000 description 1
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
229940044658 gallium nitrate Drugs 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 1
229960005277 gemcitabine Drugs 0.000 description 1
229940020967 gemzar Drugs 0.000 description 1
238000003500 gene array Methods 0.000 description 1
108091008053 gene clusters Proteins 0.000 description 1
238000011223 gene expression profiling Methods 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
230000004077 genetic alteration Effects 0.000 description 1
231100000118 genetic alteration Toxicity 0.000 description 1
230000007614 genetic variation Effects 0.000 description 1
238000011773 genetically engineered mouse model Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
210000005046 glial fibrillary acidic protein Anatomy 0.000 description 1
238000003881 globally optimized alternating phase rectangular pulse Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
235000004554 glutamine Nutrition 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
229930182470 glycoside Natural products 0.000 description 1
239000002622 gonadotropin Substances 0.000 description 1
229960003690 goserelin acetate Drugs 0.000 description 1
208000030178 grade II glioma Diseases 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000007773 growth pattern Effects 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
235000015220 hamburgers Nutrition 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
230000002440 hepatic effect Effects 0.000 description 1
239000000833 heterodimer Substances 0.000 description 1
UUVWYPNAQBNQJQ-UHFFFAOYSA-N hexamethylmelamine Chemical compound CN(C)C1=NC(N(C)C)=NC(N(C)C)=N1 UUVWYPNAQBNQJQ-UHFFFAOYSA-N 0.000 description 1
230000003118 histopathologic effect Effects 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
229940088013 hycamtin Drugs 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
229920001477 hydrophilic polymer Polymers 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
229960001330 hydroxycarbamide Drugs 0.000 description 1
238000012872 hydroxylapatite chromatography Methods 0.000 description 1
KNOSIOWNDGUGFJ-UHFFFAOYSA-N hydroxysesamone Natural products C1=CC(O)=C2C(=O)C(CC=C(C)C)=C(O)C(=O)C2=C1O KNOSIOWNDGUGFJ-UHFFFAOYSA-N 0.000 description 1
230000001146 hypoxic effect Effects 0.000 description 1
229940015872 ibandronate Drugs 0.000 description 1
229960000908 idarubicin Drugs 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
238000012744 immunostaining Methods 0.000 description 1
DBIGHPPNXATHOF-UHFFFAOYSA-N improsulfan Chemical compound CS(=O)(=O)OCCCNCCCOS(C)(=O)=O DBIGHPPNXATHOF-UHFFFAOYSA-N 0.000 description 1
229950008097 improsulfan Drugs 0.000 description 1
238000007901 in situ hybridization Methods 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
239000000893 inhibin Substances 0.000 description 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
238000007689 inspection Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
230000009545 invasion Effects 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
229960004768 irinotecan Drugs 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
238000005304 joining Methods 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
238000011813 knockout mouse model Methods 0.000 description 1
CWPGNVFCJOPXFB-UHFFFAOYSA-N lapachol Chemical compound C1=CC=C2C(=O)C(=O)C(CC=C(C)C)=C(O)C2=C1 CWPGNVFCJOPXFB-UHFFFAOYSA-N 0.000 description 1
SIUGQQMOYSVTAT-UHFFFAOYSA-N lapachol Natural products CC(=CCC1C(O)C(=O)c2ccccc2C1=O)C SIUGQQMOYSVTAT-UHFFFAOYSA-N 0.000 description 1
BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 description 1
229960001320 lapatinib ditosylate Drugs 0.000 description 1
229940115286 lentinan Drugs 0.000 description 1
229960003881 letrozole Drugs 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000001325 log-rank test Methods 0.000 description 1
YROQEQPFUCPDCP-UHFFFAOYSA-N losoxantrone Chemical compound OCCNCCN1N=C2C3=CC=CC(O)=C3C(=O)C3=C2C1=CC=C3NCCNCCO YROQEQPFUCPDCP-UHFFFAOYSA-N 0.000 description 1
229950008745 losoxantrone Drugs 0.000 description 1
229940087857 lupron Drugs 0.000 description 1
229950002654 lurtotecan Drugs 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
210000004324 lymphatic system Anatomy 0.000 description 1
235000018977 lysine Nutrition 0.000 description 1
230000002101 lytic effect Effects 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
238000002595 magnetic resonance imaging Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
208000030883 malignant astrocytoma Diseases 0.000 description 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
238000007726 management method Methods 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
239000011572 manganese Substances 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
MQXVYODZCMMZEM-ZYUZMQFOSA-N mannomustine Chemical compound ClCCNC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CNCCCl MQXVYODZCMMZEM-ZYUZMQFOSA-N 0.000 description 1
229950008612 mannomustine Drugs 0.000 description 1
229940099262 marinol Drugs 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
229960004296 megestrol acetate Drugs 0.000 description 1
SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 1
229960001924 melphalan Drugs 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
229950009246 mepitiostane Drugs 0.000 description 1
229960003151 mercaptamine Drugs 0.000 description 1
VJRAUFKOOPNFIQ-TVEKBUMESA-N methyl (1r,2r,4s)-4-[(2r,4s,5s,6s)-5-[(2s,4s,5s,6s)-5-[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylat Chemical compound O([C@H]1[C@@H](O)C[C@@H](O[C@H]1C)O[C@H]1[C@H](C[C@@H](O[C@H]1C)O[C@H]1C[C@]([C@@H](C2=CC=3C(=O)C4=C(O)C=CC(O)=C4C(=O)C=3C(O)=C21)C(=O)OC)(O)CC)N(C)C)[C@H]1C[C@H](O)[C@H](O)[C@H](C)O1 VJRAUFKOOPNFIQ-TVEKBUMESA-N 0.000 description 1
QRMNENFZDDYDEF-GOSISDBHSA-N methyl (8s)-8-(bromomethyl)-2-methyl-4-(4-methylpiperazine-1-carbonyl)oxy-6-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-7,8-dihydro-3h-pyrrolo[3,2-e]indole-1-carboxylate Chemical compound C1([C@H](CBr)CN(C1=C1)C(=O)C=2NC3=C(OC)C(OC)=C(OC)C=C3C=2)=C2C(C(=O)OC)=C(C)NC2=C1OC(=O)N1CCN(C)CC1 QRMNENFZDDYDEF-GOSISDBHSA-N 0.000 description 1
DFTAZNAEBRBBKP-UHFFFAOYSA-N methyl 4-sulfanylbutanimidate Chemical compound COC(=N)CCCS DFTAZNAEBRBBKP-UHFFFAOYSA-N 0.000 description 1
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
229960005485 mitobronitol Drugs 0.000 description 1
MXWHMTNPTTVWDM-NXOFHUPFSA-N mitoguazone Chemical compound NC(N)=N\N=C(/C)\C=N\N=C(N)N MXWHMTNPTTVWDM-NXOFHUPFSA-N 0.000 description 1
229960003539 mitoguazone Drugs 0.000 description 1
VFKZTMPDYBFSTM-GUCUJZIJSA-N mitolactol Chemical compound BrC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CBr VFKZTMPDYBFSTM-GUCUJZIJSA-N 0.000 description 1
229950010913 mitolactol Drugs 0.000 description 1
229960004857 mitomycin Drugs 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
229960000350 mitotane Drugs 0.000 description 1
201000004058 mixed glioma Diseases 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
239000003607 modifier Substances 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
239000003147 molecular marker Substances 0.000 description 1
230000004784 molecular pathogenesis Effects 0.000 description 1
239000000178 monomer Substances 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
229960000951 mycophenolic acid Drugs 0.000 description 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
AZBFJBJXUQUQLF-UHFFFAOYSA-N n-(1,5-dimethylpyrrolidin-3-yl)pyrrolidine-1-carboxamide Chemical compound C1N(C)C(C)CC1NC(=O)N1CCCC1 AZBFJBJXUQUQLF-UHFFFAOYSA-N 0.000 description 1
NJSMWLQOCQIOPE-OCHFTUDZSA-N n-[(e)-[10-[(e)-(4,5-dihydro-1h-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1h-imidazol-2-amine Chemical compound N1CCN=C1N\N=C\C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1\C=N\NC1=NCCN1 NJSMWLQOCQIOPE-OCHFTUDZSA-N 0.000 description 1
BLCLNMBMMGCOAS-UHFFFAOYSA-N n-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amin Chemical compound C1CCC(C(=O)NNC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(COC(C)(C)C)NC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 BLCLNMBMMGCOAS-UHFFFAOYSA-N 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
229940086322 navelbine Drugs 0.000 description 1
230000027498 negative regulation of mitosis Effects 0.000 description 1
MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
206010061311 nervous system neoplasm Diseases 0.000 description 1
210000005055 nestin Anatomy 0.000 description 1
101150006061 neur gene Proteins 0.000 description 1
210000000933 neural crest Anatomy 0.000 description 1
210000000276 neural tube Anatomy 0.000 description 1
208000027831 neuroepithelial neoplasm Diseases 0.000 description 1
230000009223 neuronal apoptosis Effects 0.000 description 1
XWXYUMMDTVBTOU-UHFFFAOYSA-N nilutamide Chemical compound O=C1C(C)(C)NC(=O)N1C1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 XWXYUMMDTVBTOU-UHFFFAOYSA-N 0.000 description 1
229960002653 nilutamide Drugs 0.000 description 1
VFEDRRNHLBGPNN-UHFFFAOYSA-N nimustine Chemical compound CC1=NC=C(CNC(=O)N(CCCl)N=O)C(N)=N1 VFEDRRNHLBGPNN-UHFFFAOYSA-N 0.000 description 1
229960001420 nimustine Drugs 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
KGTDRFCXGRULNK-JYOBTZKQSA-N nogalamycin Chemical compound CO[C@@H]1[C@@](OC)(C)[C@@H](OC)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=C(O)C=C4[C@@]5(C)O[C@H]([C@H]([C@@H]([C@H]5O)N(C)C)O)OC4=C3C3=O)=C3C=C2[C@@H](C(=O)OC)[C@@](C)(O)C1 KGTDRFCXGRULNK-JYOBTZKQSA-N 0.000 description 1
229950009266 nogalamycin Drugs 0.000 description 1
229940085033 nolvadex Drugs 0.000 description 1
208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
238000012758 nuclear staining Methods 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
CZDBNBLGZNWKMC-MWQNXGTOSA-N olivomycin Chemical class O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1)O[C@H]1O[C@@H](C)[C@H](O)[C@@H](OC2O[C@@H](C)[C@H](O)[C@@H](O)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@H](O)[C@H](OC)[C@H](C)O1 CZDBNBLGZNWKMC-MWQNXGTOSA-N 0.000 description 1
229950011093 onapristone Drugs 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
238000011369 optimal treatment Methods 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000002138 osteoinductive effect Effects 0.000 description 1
229940043515 other immunoglobulins in atc Drugs 0.000 description 1
229940046231 pamidronate Drugs 0.000 description 1
VREZDOWOLGNDPW-UHFFFAOYSA-N pancratistatine Natural products C1=C2C3C(O)C(O)C(O)C(O)C3NC(=O)C2=C(O)C2=C1OCO2 VREZDOWOLGNDPW-UHFFFAOYSA-N 0.000 description 1
201000002528 pancreatic cancer Diseases 0.000 description 1
208000008443 pancreatic carcinoma Diseases 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
229940055729 papain Drugs 0.000 description 1
239000000199 parathyroid hormone Substances 0.000 description 1
229960001319 parathyroid hormone Drugs 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
229960002340 pentostatin Drugs 0.000 description 1
FPVKHBSQESCIEP-JQCXWYLXSA-N pentostatin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC[C@H]2O)=C2N=C1 FPVKHBSQESCIEP-JQCXWYLXSA-N 0.000 description 1
QIMGFXOHTOXMQP-GFAGFCTOSA-N peplomycin Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCCN[C@@H](C)C=1C=CC=CC=1)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1NC=NC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C QIMGFXOHTOXMQP-GFAGFCTOSA-N 0.000 description 1
229950003180 peplomycin Drugs 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
230000008782 phagocytosis Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
229960000952 pipobroman Drugs 0.000 description 1
NJBFOOCLYDNZJN-UHFFFAOYSA-N pipobroman Chemical compound BrCCC(=O)N1CCN(C(=O)CCBr)CC1 NJBFOOCLYDNZJN-UHFFFAOYSA-N 0.000 description 1
NUKCGLDCWQXYOQ-UHFFFAOYSA-N piposulfan Chemical compound CS(=O)(=O)OCCC(=O)N1CCN(C(=O)CCOS(C)(=O)=O)CC1 NUKCGLDCWQXYOQ-UHFFFAOYSA-N 0.000 description 1
229950001100 piposulfan Drugs 0.000 description 1
229960001221 pirarubicin Drugs 0.000 description 1
108010017843 platelet-derived growth factor A Proteins 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
150000003057 platinum Chemical class 0.000 description 1
YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
229960001237 podophyllotoxin Drugs 0.000 description 1
YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
229960004694 prednimustine Drugs 0.000 description 1
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
229960005205 prednisolone Drugs 0.000 description 1
229960004618 prednisone Drugs 0.000 description 1
XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000003623 progesteronic effect Effects 0.000 description 1
230000005522 programmed cell death Effects 0.000 description 1
229940097325 prolactin Drugs 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001902 propagating effect Effects 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
108010087851 prorelaxin Proteins 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
230000012743 protein tagging Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
WOLQREOUPKZMEX-UHFFFAOYSA-N pteroyltriglutamic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(=O)NC(CCC(=O)NC(CCC(O)=O)C(O)=O)C(O)=O)C(O)=O)C=C1 WOLQREOUPKZMEX-UHFFFAOYSA-N 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
229950010131 puromycin Drugs 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
UOWVMDUEMSNCAV-WYENRQIDSA-N rachelmycin Chemical compound C1([C@]23C[C@@H]2CN1C(=O)C=1NC=2C(OC)=C(O)C4=C(C=2C=1)CCN4C(=O)C1=CC=2C=4CCN(C=4C(O)=C(C=2N1)OC)C(N)=O)=CC(=O)C1=C3C(C)=CN1 UOWVMDUEMSNCAV-WYENRQIDSA-N 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
BMKDZUISNHGIBY-UHFFFAOYSA-N razoxane Chemical compound C1C(=O)NC(=O)CN1C(C)CN1CC(=O)NC(=O)C1 BMKDZUISNHGIBY-UHFFFAOYSA-N 0.000 description 1
229960000460 razoxane Drugs 0.000 description 1
230000007420 reactivation Effects 0.000 description 1
238000003753 real-time PCR Methods 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000022983 regulation of cell cycle Effects 0.000 description 1
108010064950 regulator of g-protein signaling 9 Proteins 0.000 description 1
239000003488 releasing hormone Substances 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
238000003757 reverse transcription PCR Methods 0.000 description 1
OWPCHSCAPHNHAV-LMONGJCWSA-N rhizoxin Chemical compound C/C([C@H](OC)[C@@H](C)[C@@H]1C[C@H](O)[C@]2(C)O[C@@H]2/C=C/[C@@H](C)[C@]2([H])OC(=O)C[C@@](C2)(C[C@@H]2O[C@H]2C(=O)O1)[H])=C\C=C\C(\C)=C\C1=COC(C)=N1 OWPCHSCAPHNHAV-LMONGJCWSA-N 0.000 description 1
229940089617 risedronate Drugs 0.000 description 1
229950004892 rodorubicin Drugs 0.000 description 1
MBABCNBNDNGODA-WPZDJQSSSA-N rolliniastatin 1 Natural products O1[C@@H]([C@@H](O)CCCCCCCCCC)CC[C@H]1[C@H]1O[C@@H]([C@H](O)CCCCCCCCCC[C@@H](O)CC=2C(O[C@@H](C)C=2)=O)CC1 MBABCNBNDNGODA-WPZDJQSSSA-N 0.000 description 1
IMUQLZLGWJSVMV-UOBFQKKOSA-N roridin A Natural products CC(O)C1OCCC(C)C(O)C(=O)OCC2CC(=CC3OC4CC(OC(=O)C=C/C=C/1)C(C)(C23)C45CO5)C IMUQLZLGWJSVMV-UOBFQKKOSA-N 0.000 description 1
VHXNKPBCCMUMSW-FQEVSTJZSA-N rubitecan Chemical compound C1=CC([N+]([O-])=O)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VHXNKPBCCMUMSW-FQEVSTJZSA-N 0.000 description 1
229930182947 sarcodictyin Natural products 0.000 description 1
238000013391 scatchard analysis Methods 0.000 description 1
239000006152 selective media Substances 0.000 description 1
230000003007 single stranded DNA break Effects 0.000 description 1
229960002930 sirolimus Drugs 0.000 description 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
229950001403 sizofiran Drugs 0.000 description 1
229940112726 skelid Drugs 0.000 description 1
108010039827 snRNP Core Proteins Proteins 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
PTLRDCMBXHILCL-UHFFFAOYSA-M sodium arsenite Chemical compound [Na+].[O-][As]=O PTLRDCMBXHILCL-UHFFFAOYSA-M 0.000 description 1
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
229940048086 sodium pyrophosphate Drugs 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
108010082379 somatostatin receptor type 1 Proteins 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
229950006315 spirogermanium Drugs 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
ICXJVZHDZFXYQC-UHFFFAOYSA-N spongistatin 1 Natural products OC1C(O2)(O)CC(O)C(C)C2CCCC=CC(O2)CC(O)CC2(O2)CC(OC)CC2CC(=O)C(C)C(OC(C)=O)C(C)C(=C)CC(O2)CC(C)(O)CC2(O2)CC(OC(C)=O)CC2CC(=O)OC2C(O)C(CC(=C)CC(O)C=CC(Cl)=C)OC1C2C ICXJVZHDZFXYQC-UHFFFAOYSA-N 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000011301 standard therapy Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
229960001052 streptozocin Drugs 0.000 description 1
ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
108010090953 subunit 1 GABA type B receptor Proteins 0.000 description 1
229940014800 succinic anhydride Drugs 0.000 description 1
150000005846 sugar alcohols Chemical class 0.000 description 1
210000001258 synovial membrane Anatomy 0.000 description 1
229940120982 tarceva Drugs 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 1
229960001278 teniposide Drugs 0.000 description 1
229960005353 testolactone Drugs 0.000 description 1
BPEWUONYVDABNZ-DZBHQSCQSA-N testolactone Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(OC(=O)CC4)[C@@H]4[C@@H]3CCC2=C1 BPEWUONYVDABNZ-DZBHQSCQSA-N 0.000 description 1
235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
231100001274 therapeutic index Toxicity 0.000 description 1
238000011285 therapeutic regimen Methods 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
229940034208 thyroxine Drugs 0.000 description 1
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
YFTWHEBLORWGNI-UHFFFAOYSA-N tiamiprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC(N)=NC2=C1NC=N2 YFTWHEBLORWGNI-UHFFFAOYSA-N 0.000 description 1
229950011457 tiamiprine Drugs 0.000 description 1
229940019375 tiludronate Drugs 0.000 description 1
230000008467 tissue growth Effects 0.000 description 1
RUELTTOHQODFPA-UHFFFAOYSA-N toluene 2,6-diisocyanate Chemical compound CC1=C(N=C=O)C=CC=C1N=C=O RUELTTOHQODFPA-UHFFFAOYSA-N 0.000 description 1
229940044693 topoisomerase inhibitor Drugs 0.000 description 1
229960005026 toremifene Drugs 0.000 description 1
230000007888 toxin activity Effects 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
IUCJMVBFZDHPDX-UHFFFAOYSA-N tretamine Chemical compound C1CN1C1=NC(N2CC2)=NC(N2CC2)=N1 IUCJMVBFZDHPDX-UHFFFAOYSA-N 0.000 description 1
229950001353 tretamine Drugs 0.000 description 1
PXSOHRWMIRDKMP-UHFFFAOYSA-N triaziquone Chemical compound O=C1C(N2CC2)=C(N2CC2)C(=O)C=C1N1CC1 PXSOHRWMIRDKMP-UHFFFAOYSA-N 0.000 description 1
229960004560 triaziquone Drugs 0.000 description 1
229930013292 trichothecene Natural products 0.000 description 1
150000003327 trichothecene derivatives Chemical class 0.000 description 1
KVJXBPDAXMEYOA-CXANFOAXSA-N trilostane Chemical compound OC1=C(C#N)C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@@]32O[C@@H]31 KVJXBPDAXMEYOA-CXANFOAXSA-N 0.000 description 1
229960001670 trilostane Drugs 0.000 description 1
WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 1
NOYPYLRCIDNJJB-UHFFFAOYSA-N trimetrexate Chemical compound COC1=C(OC)C(OC)=CC(NCC=2C(=C3C(N)=NC(N)=NC3=CC=2)C)=C1 NOYPYLRCIDNJJB-UHFFFAOYSA-N 0.000 description 1
229960001099 trimetrexate Drugs 0.000 description 1
229950000212 trioxifene Drugs 0.000 description 1
HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
229940038773 trisodium citrate Drugs 0.000 description 1
229960000875 trofosfamide Drugs 0.000 description 1
UMKFEPPTGMDVMI-UHFFFAOYSA-N trofosfamide Chemical compound ClCCN(CCCl)P1(=O)OCCCN1CCCl UMKFEPPTGMDVMI-UHFFFAOYSA-N 0.000 description 1
229950010147 troxacitabine Drugs 0.000 description 1
RXRGZNYSEHTMHC-BQBZGAKWSA-N troxacitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)OC1 RXRGZNYSEHTMHC-BQBZGAKWSA-N 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
HDZZVAMISRMYHH-LITAXDCLSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O HDZZVAMISRMYHH-LITAXDCLSA-N 0.000 description 1
239000000439 tumor marker Substances 0.000 description 1
102000003390 tumor necrosis factor Human genes 0.000 description 1
230000005751 tumor progression Effects 0.000 description 1
208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
230000002476 tumorcidal effect Effects 0.000 description 1
231100000588 tumorigenic Toxicity 0.000 description 1
230000000381 tumorigenic effect Effects 0.000 description 1
229950009811 ubenimex Drugs 0.000 description 1
229960001055 uracil mustard Drugs 0.000 description 1
230000007556 vascular defect Effects 0.000 description 1
210000005048 vimentin Anatomy 0.000 description 1
UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 description 1
GBABOYUKABKIAF-IELIFDKJSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-IELIFDKJSA-N 0.000 description 1
229960002066 vinorelbine Drugs 0.000 description 1
229960001771 vorozole Drugs 0.000 description 1
XLYOFNOQVPJJNP-OUBTZVSYSA-N water-17o Chemical compound [17OH2] XLYOFNOQVPJJNP-OUBTZVSYSA-N 0.000 description 1
230000029663 wound healing Effects 0.000 description 1
229940053867 xeloda Drugs 0.000 description 1
229950009268 zinostatin Drugs 0.000 description 1
XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 description 1
229940002005 zometa Drugs 0.000 description 1
FBTUMDXHSRTGRV-ALTNURHMSA-N zorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(\C)=N\NC(=O)C=1C=CC=CC=1)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 FBTUMDXHSRTGRV-ALTNURHMSA-N 0.000 description 1
229960000641 zorubicin Drugs 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Oncology (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Hematology (AREA)
Biochemistry (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Genetics & Genomics (AREA)
Hospice & Palliative Care (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
General Physics & Mathematics (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA002633593A 2005-12-16 2006-12-11 Methode de diagnostic, de pronostic et de traitement du gliome Abandoned CA2633593A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US75094405P	2005-12-16	2005-12-16
US60/750,944		2005-12-16
PCT/US2006/061869 WO2007111733A2 (fr)	2005-12-16	2006-12-11	Méthode de diagnostic, de pronostic et de traitement du gliome

Publications (1)

Publication Number	Publication Date
CA2633593A1 true CA2633593A1 (fr)	2007-10-04

Family

ID=38541595

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002633593A Abandoned CA2633593A1 (fr)	2005-12-16	2006-12-11	Methode de diagnostic, de pronostic et de traitement du gliome

Country Status (12)

Country	Link
US (1)	US20070141066A1 (fr)
EP (1)	EP1960552A2 (fr)
JP (1)	JP2009523709A (fr)
KR (1)	KR20080087822A (fr)
CN (1)	CN101336300A (fr)
AU (1)	AU2006340769A1 (fr)
BR (1)	BRPI0620695A2 (fr)
CA (1)	CA2633593A1 (fr)
IL (1)	IL191538A0 (fr)
MX (1)	MX2008007650A (fr)
RU (1)	RU2008129028A (fr)
WO (1)	WO2007111733A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10181008B2 (en)	2013-05-30	2019-01-15	Genomic Health, Inc.	Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
US10892038B2 (en)	2010-01-11	2021-01-12	Genomic Health, Inc.	Method to use gene expression to determine likelihood of clinical outcome of renal cancer

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2607455A1 (fr) *	2005-04-22	2006-11-02	Morphotek, Inc.	Anticorps a activite d'effecteur immunitaire et internalises dans des cellules positives vis-a-vis de l'endosialine
JP4867018B2 (ja) *	2006-03-22	2012-02-01	富士フイルム株式会社	癌の検出方法および抑制方法
WO2008124570A1 (fr)	2007-04-05	2008-10-16	Morphotek, Inc.	Procédés pour inhiber la liaison de l'endosialine à des ligands
WO2009014565A2 (fr) *	2007-04-26	2009-01-29	Ludwig Institute For Cancer Research, Ltd.	Procédés pour le diagnostic et le traitement des astrocytomes
US20100255514A1 (en) *	2007-08-16	2010-10-07	The Royal Institution For The Advancement Of Learning/Mcgill University	Tumor cell-derived microvesicles
EP2176665B1 (fr)	2007-08-16	2016-03-02	The Royal Institution for the Advancement of Learning / McGill University	Microvesicules issues d'une cellule tumorale
US20110160072A1 (en) *	2007-10-23	2011-06-30	Clinical Genomics Pty. Ltd.	Method of diagnosing neoplasms
WO2009087689A2 (fr) *	2008-01-07	2009-07-16	Council Of Scientific & Industrial Research	Nouvelles amorces pour l'identification d'un astrocytome, de ses grades et le pronostic d'un glioblastome
DE102008011850A1 (de) *	2008-02-29	2009-09-03	Michael Grzendowski	Biomarker für die Diagnose von Hirntumor
WO2009150255A2 (fr) *	2008-06-13	2009-12-17	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Marqueurs destinés à prédire la réponse et la survie de patients traités anti-egfr
JP5461959B2 (ja) *	2008-10-31	2014-04-02	株式会社Ｄｎａチップ研究所	神経膠腫予後予測方法、およびそれに用いるキット
WO2011007801A1 (fr) *	2009-07-15	2011-01-20	株式会社エムシープロット・バイオテクノロジー	Agent anticancéreux, procédé d'induction de l'apoptose de cellules cancéreuses et procédé de criblage d'un agent anticancéreux
WO2015077725A1 (fr) *	2013-11-22	2015-05-28	Dignity Health	Diagnostic de sous-groupes liés à idh1 et traitement du cancer
US10731221B2 (en) *	2009-12-11	2020-08-04	Dignity Health	Diagnosing IDH1 related subgroups and treatment of cancer
DK3342786T3 (en)	2010-01-29	2021-09-27	Chugai Pharmaceutical Co Ltd	Anti-dll3-antistof
RU2439577C2 (ru) *	2010-02-25	2012-01-10	Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи"	Способ прогнозирования выживаемости больных злокачественными глиомами
RS65813B1 (sr)	2011-04-29	2024-08-30	Penn State Res Found	Indukcija malog molekula trail genom u normalnim i tumorskim ćelijama kao antikancerska terapija
WO2012166722A1 (fr) *	2011-06-03	2012-12-06	The General Hospital Corporation	Traitement du cancer colorectal, pancréatique et pulmonaire
CN103945860A (zh)	2011-09-20	2014-07-23	布莱根妇女医院	Sall4和其用途
CN103930132A (zh)	2011-09-27	2014-07-16	拜奥迈德瓦利探索有限公司	治疗胶质瘤的组合物和方法
ES2812849T3 (es) *	2012-02-24	2021-03-18	Abbvie Stemcentrx Llc	Anticuerpos anti-DLL3 y procedimientos de utilización de los mismos
GB201302447D0 (en) *	2013-02-12	2013-03-27	Oxford Biotherapeutics Ltd	Therapeutic and diagnostic target
WO2014130879A2 (fr)	2013-02-22	2014-08-28	Stem Centrx, Inc.	Nouveaux conjugués anticorps et leurs utilisations
CN104178556B (zh) *	2013-05-28	2016-08-17	北京师范大学	神经胶质瘤分子分型基因群及其应用
PE20160674A1 (es)	2013-08-28	2016-07-21	Stemcentrx Inc	Metodos de conjugacion de anticuerpos especificos de sitio y composiciones
EP3338793A1 (fr)	2013-08-28	2018-06-27	AbbVie Stemcentrx LLC	Nouveaux modulateurs sez6 et procédés d'utilisation
AU2014312210A1 (en) *	2013-08-28	2016-04-07	Abbvie Stemcentrx Llc	Engineered anti-DLL3 conjugates and methods of use
US10617755B2 (en)	2013-08-30	2020-04-14	Genentech, Inc.	Combination therapy for the treatment of glioblastoma
US10456470B2 (en)	2013-08-30	2019-10-29	Genentech, Inc.	Diagnostic methods and compositions for treatment of glioblastoma
CN105934256B (zh) *	2013-12-03	2019-12-27	拜耳制药股份公司	Pi3k-抑制剂的组合产品
EA201691683A1 (ru)	2014-02-21	2017-04-28	ЭББВИ СТЕМСЕНТРКС ЭлЭлСи	Антитела против dll3 и конъюгаты антитело-лекарственное средство для применения при меланоме
EP3169801A1 (fr) *	2014-07-14	2017-05-24	F. Hoffmann-La Roche AG	Méthodes diagnostiques et compositions pour le traitement du glioblastome
AU2016229710B2 (en) *	2015-03-06	2019-05-09	Cell&Brain Co., Ltd	Cell therapeutic agent for cancer treatment and combination therapy with same
TWI793062B (zh) *	2015-07-31	2023-02-21	德商安美基研究（慕尼黑）公司	Ｄｌｌ３及ｃｄ３抗體構築體
CN105861696B (zh) *	2016-05-13	2019-12-06	万康源(天津)基因科技有限公司	一种基于转录组的肿瘤转移基因检测系统
EP4520828A3 (fr) *	2016-11-15	2025-07-09	The Schepens Eye Research Institute, Inc.	Compositions et procédés pour le traitement de l'angiogenèse aberrante
CN106754433B (zh) *	2017-02-22	2019-07-02	佛山市海天调味食品股份有限公司	一种渗透压稳定剂及其用途
EP3477305A1 (fr) *	2017-10-25	2019-05-01	Universität Heidelberg	Ligand 1 de type delta pour diagnostiquer des infections graves
JP7416700B2 (ja)	2017-11-14	2024-01-17	ザスキーペンズアイリサーチインスティチュートインコーポレイテッド	増殖性硝子体網膜症および上皮間葉転換と関連付けられる状態の治療のためのｒｕｎｘ１阻害の方法
WO2019131988A1 (fr)	2017-12-28	2019-07-04	Chugai Seiyaku Kabushiki Kaisha	Agent thérapeutique induisant une cytotoxicité
US11490603B2 (en)	2018-02-06	2022-11-08	Korea Advanced Institute Of Science And Technology	Animal model of brain tumor and manufacturing method of animal model
TWI848953B (zh)	2018-06-09	2024-07-21	德商百靈佳殷格翰國際股份有限公司	針對癌症治療之多特異性結合蛋白
CN109307764B (zh) *	2018-10-29	2021-09-17	郑州大学第一附属医院	一组代谢标志物在制备胶质瘤诊断试剂盒方面的应用
RU2709651C1 (ru) *	2018-11-29	2019-12-19	Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации	Способ дифференциальной диагностики глиом на основании анализа экспрессии генов и микро-рнк
CN109913549B (zh) *	2019-03-07	2021-02-05	北京师范大学	基于cdc20基因共表达网络的胶质瘤分子分型及应用
WO2020224159A1 (fr) *	2019-05-06	2020-11-12	臻和精准医学检验实验室无锡有限公司	Panneau à base de séquençage de nouvelle génération pour la détection de gliome, kit de détection, procédé de détection et application correspondante
PH12022500013A1 (en)	2020-03-31	2023-09-11	Chugai Pharmaceutical Co Ltd	Dll3-targeting multispecific antigen-binding molecules and uses thereof
AU2021337678A1 (en) *	2020-09-02	2023-04-13	The General Hospital Corporation	Methods for identifying cross-modal features from spatially resolved data sets
CN115310290B (zh) *	2022-08-10	2023-04-07	南宁师范大学	一种荔枝区域产量年型预测模型的构建方法
WO2024102177A1 (fr) *	2022-11-08	2024-05-16	The Regents Of The University Of California	Polythérapies pour le traitement du cancer du cerveau

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001036685A2 (fr) *	1999-11-17	2001-05-25	Nyxis Neurotherapies, Inc.	Expression differentielle de genes dans le cancer
CN1968706A (zh) *	2004-06-03	2007-05-23	霍夫曼-拉罗奇有限公司	用顺铂和egfr－抑制剂治疗

2006
- 2006-12-11 JP JP2008545929A patent/JP2009523709A/ja active Pending
- 2006-12-11 US US11/609,071 patent/US20070141066A1/en not_active Abandoned
- 2006-12-11 MX MX2008007650A patent/MX2008007650A/es not_active Application Discontinuation
- 2006-12-11 RU RU2008129028/14A patent/RU2008129028A/ru not_active Application Discontinuation
- 2006-12-11 CA CA002633593A patent/CA2633593A1/fr not_active Abandoned
- 2006-12-11 BR BRPI0620695-6A patent/BRPI0620695A2/pt not_active Application Discontinuation
- 2006-12-11 AU AU2006340769A patent/AU2006340769A1/en not_active Abandoned
- 2006-12-11 WO PCT/US2006/061869 patent/WO2007111733A2/fr not_active Ceased
- 2006-12-11 CN CNA2006800523281A patent/CN101336300A/zh active Pending
- 2006-12-11 KR KR1020087017185A patent/KR20080087822A/ko not_active Withdrawn
- 2006-12-11 EP EP06850267A patent/EP1960552A2/fr not_active Withdrawn
2008
- 2008-05-19 IL IL191538A patent/IL191538A0/en unknown

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10892038B2 (en)	2010-01-11	2021-01-12	Genomic Health, Inc.	Method to use gene expression to determine likelihood of clinical outcome of renal cancer
US11776664B2 (en)	2010-01-11	2023-10-03	Genomic Health, Inc.	Method to use gene expression to determine likelihood of clinical outcome of renal cancer
US12412642B2 (en)	2010-01-11	2025-09-09	Genomic Health, Inc.	Method to use gene expression to determine likelihood of clinical outcome of renal cancer
US10181008B2 (en)	2013-05-30	2019-01-15	Genomic Health, Inc.	Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
US11551782B2 (en)	2013-05-30	2023-01-10	Genomic Health, Inc.	Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer

Also Published As

Publication number	Publication date
KR20080087822A (ko)	2008-10-01
WO2007111733A3 (fr)	2008-04-10
AU2006340769A2 (en)	2008-06-19
RU2008129028A (ru)	2010-01-27
EP1960552A2 (fr)	2008-08-27
CN101336300A (zh)	2008-12-31
IL191538A0 (en)	2008-12-29
JP2009523709A (ja)	2009-06-25
MX2008007650A (es)	2008-10-20
US20070141066A1 (en)	2007-06-21
BRPI0620695A2 (pt)	2011-11-22
WO2007111733A2 (fr)	2007-10-04
AU2006340769A1 (en)	2007-10-04

Publication	Publication Date	Title
CA2633593A1 (fr)	2007-10-04	Methode de diagnostic, de pronostic et de traitement du gliome
AU2008218199B2 (en)	2013-10-31	Methods for detecting inflammatory bowel disease
US8398982B2 (en)	2013-03-19	Compositions and methods for the diagnosis and treatment of tumor
US20090142259A1 (en)	2009-06-04	Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
EP2849789A1 (fr)	2015-03-25	Compositions et méthodes destinées à diagnostiquer et à traiter des tumeurs
US20090054631A1 (en)	2009-02-26	Compositions and methods for treatment of non-hodgkin's lymphoma
US20090155788A1 (en)	2009-06-18	Gene expression markers for inflammatory bowel disease
KR20130079384A (ko)	2013-07-10	종양의 진단 및 치료를 위한 조성물 및 방법
CA2647277A1 (fr)	2007-11-08	Methode d'utilisation du boc/cdo pour moduler l'emission des signaux du hedgehog
US20080193446A1 (en)	2008-08-14	Compositions and Methods for the Diagnosis and Treatment of Tumor
AU2006235436A2 (en)	2006-10-19	Compositions and methods for the diagnosis and treatment of tumor

Legal Events

Date	Code	Title	Description
2010-12-13	FZDE	Discontinued